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ABSTRACT
THE DISCOVERY AND EXPLORATION OF A UNIVERSAL TARGETING
MECHANISM IN EUKARYOTIC CELLS

Priyanka Sivadas, B.Tech
Marquette University, 2011

A wide range of eukaryotic organisms generate motile cilia and flagella. These
slender organelles beat rhythmically to move the surrounding fluid or to propel cells in
aqueous environment. Organisms use these powerful yet nimble organelles to forage,
evade, adapt and mate. The machinery that drives this tightly controlled movement is the
sophisticated microtubule-based axoneme. As it is critical for the survival of individual
species, this machinery has largely been preserved to the molecular level throughout
evolution. Proteomic studies have shown that most proteins in this biological machine
consist of molecular modules commonly used in the cell body. But the usage of these
modules is clearly diverged in many cases. This defined machinery with diverged
applications provides an opportunity to understand the true capacity of the conserved
modules. One example is the radial spoke (RS) that controls the oscillatory beating. This
macromolecular complex contains complementary molecular modules that are
responsible for localizing cAMP-dependent protein kinase (PKA) in the cell body.
However, the RS does not have the features that account for the effector mechanisms of
PKA and thus the mechanism discovered for localizing PKA has a broader role that has
previously not been recognized. The work described in this dissertation discovered that
the core of the RS utilizes two similar sets of PKA anchoring modules for four distinct
effector mechanisms that underlie the assembly and function of this regulatory complex.
These results elucidate the function of this complex and are applicable to more than 600
diverged proteins that also share the docking module of PKA. Some of them have been
shown to play vital roles in myriads of cellular reactions ranging from flagellar beating to
trans-Golgi trafficking to chromosome modifications. Founded on this discovery, new
reagents and assays were engineered. These tools could be used for the exploration of
proteins with similar docking and anchoring modules. Together, these findings will
accelerate the advancements in the field of anchoring and docking of proteins in the cell.
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Chapter 1: Introduction

1.1 Cilia and Flagella
Cilia and flagella are hair-like organelles adopted by unicellular and multicellular
organisms alike. Albeit differing in length and number, the fundamental structure and
mechanism of these organelles are identical. Discoveries over the past decade have
revealed their broad significance for a wide range of cell types and tissues. Yet the
mechanisms related to the generation, function and maintenance of cilia and flagella are
just emerging. Recent genomic and proteomic tools have hastened the identification of
new proteins and molecular domains within these organelles. While some of these
molecular domains appear to be cilia-specific, most are utilized in other cellular
compartments as well. The proteins with these widely utilized molecular domains have
become new targets for focused investigation. Elucidation of these key proteins and
molecular domains will shed critical insight on these important organelles and will
provide a solid foundation to understand and treat congenital disorders and diseases
related to these organelles.

1.1.1 The Function and Significance
Cilia and flagella are analogous to cellular antennae, sensing environmental conditions
for cells. Some cilia and flagella are also motile with tightly controlled rhythmic
movement (Ishikawa and Marshall, 2011). These two main functions seem unrelated to
each other, yet in many instances they are tightly coupled, providing cells the means to
sense the environment and then respond accordingly.
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The importance of these dual functional organelles has been recognized for three
decades (Pederson and Rebbe, 1975; Afzelius, 1979 and 1981). However, the broad
impact of the sensory function in mammals did not emerge until about 10 years ago
(Pazour et al., 2000). As sensory organelles, the compartmentalized ciliary membrane is
enriched with various channels (Singla and Reiter, 2006; Rohatgi et al., 2007;
Hildebrandt et al., 2011) and vital receptors, like those for hedgehog, Patched, growth
factors, hormones and those coupled to G proteins. For instance, in kidney, the primary
cilium of the tubular epithelium senses the fluid flowing through the tubules using
mechano-sensitive calcium channels. The fluid flow deforms the cilia which lead to
opening of the channels. The calcium influx induces a cascade of signal transduction
pathways which maintain the polarity and the homeostasis of the epithelium (Nauli et al.,
2003; Dalagiorgou et al., 2010). Defects in these cilia, whether they are ciliogenesis,
sensing or signal transduction defects, result in dedifferentiation and unchecked mitosis
of the tubular epithelial cells (Praetorius and Spring, 2003; Liu et al., 2005; Deane and
Ricardo, 2007; Belibi et al., 2010). Clinically, these responses are manifested as a rather
common disorder, polycystic kidney disease (PKD) (Pazour et al., 2000). By the same
token, sensory cilia are pertinent to the development and maintenance of homeostasis of
most organs (Hirokawa et al., 2009; Snell et al., 2004). Thus defects in the sensory
function are also manifested as situs inversus, polydactyly, blindness, deafness, diabetes,
obesity and hypertension (Lee, 2011).
Motile cilia are important as well, albeit for different purposes. Most eukaryotic
organisms generate motile cilia at a certain phase of their life cycle. Their distribution in
multicellular organisms is mostly restricted to the respiratory system, ventricle of the
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brain and reproductive organs (Baker and Beales, 2009). In the respiratory tract, motile
cilia constantly propel mucus overlying the epithelium, along with trapped
microorganisms, harmful compounds and irritating particulates. Ineffective mucociliary
clearance from the respiratory tract leads to chronic respiratory infection and ultimately
bronchiectasis and the need for a lung transplant (Lee, 2011). Motile cilia of the
ependymal cells surrounding the ventricle of the brain circulate the cerebrospinal fluid
(CSF). The purpose of the flow of CSF is not entirely clear. However, defects in
ependymal cilia lead to stagnant CSF, increased ventricular pressure, hydrocephaly and
loss of cortical neurons (Lee, 2011). During development, the cilia in the node play a
critical role in the polarized distribution of morphogens that determine the development
of left right asymmetry (Nonaka et al., 2002). Defects in nodal cilia result in situs
inversus -- the internal organs are distributed in a mirror image of the normal pattern.
Lastly, in the reproductive system motile cilia are crucial for fertility. In the female
reproductive system, the cilia lining the fallopian tube help in the transport of the egg
from the ovary to the uterus (Lyons et al., 2006). In the male reproductive system, a
single flagellum propels the sperm towards the oocytes (Kaupp et al., 2008). Defective
motility in these cilia impairs male and female fertility. Together these symptoms due to
defective motility are referred to as primary ciliary dyskinesia (PCD) or Kartagener
syndrome (Kartagener, 1933; Afzelius, 1976 and 1981).
As the motility machinery is comprised of hundreds of distinct polypeptides, PCD
is a polygenic congenital disorder. At least 1 in 16,000 people are afflicted with PCD
(Lee, 2011), yet the true incidence is likely to be higher since the symptoms, albeit
diminishing the quality of life, are not life threatening. Understanding the molecular
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mechanism of the motility machinery will provide a solid foundation for the diagnosis
and treatment of PCD patients.

1.1.2 The 9+2 Axoneme
Regardless of the variety, all motile cilia and flagella contain a microtubule-based
scaffold, the axoneme. Barring a few exceptions, a majority of them employ the 9+2
format (Li et al., 2004; Hoops and Witman, 1983; Schrevel and Besse, 1975). It consists
of nine outer microtubule doublets encircling two singlet microtubules. In contrast, the
axoneme in immotile sensory cilia appears more primitive. Most still have
9 outer doublets but the central pair of singlet microtubules is absent. Hence they are
referred to as the 9+0 format. Exceptions are found in some cell types. For example,
some motile cilia that beat with less sophisticated motion adopt 9+0 axonemes (Okada et
al., 1999).
In the 9+2 axoneme, the microtubule scaffold is associated with several
distinctive molecular complexes. It is the axonemal complexes that enable these
machines to beat with extraordinary capacity. It is not conducive to study this motility
machinery using higher organisms because of its complicated composition and
mechanism. Most of our current understanding of this complex machinery is derived
from investigation of the 9+2 axoneme in the biflagellate model organism,
Chlamydomonas reinhardtii.

1.2 9+2 Machinery
The 9+2 axoneme is highly conserved (Figure 1-1). It consists of 9 outer microtubule
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doublets surrounding 2 microtubule singlets. Each doublet is comprised of a complete A
tubule and a partial B tubule (Satir, 1980). The 9+2 axoneme contains all of the
machinery and regulatory elements necessary for the controlled movement. Isolated
axonemes, without the plasma membrane and cytoplasm, can be reactivated to beat
rhythmically when ATP is provided (Summers and Gibbons, 1971). In addition, this
movement is sensitive to calcium and cAMP (Kamiya and Witman, 1984). The controlled
movement relies on the many molecular complexes associated with the 9+2 microtubule
platform. The complexes that are easily visible in electron micrographs are best
characterized.
The two microtubule singlets in the center of the axoneme associate with multiple
projections. Together these structures in the center of the axoneme are referred to as the
central pair (CP) apparatus. Outer dynein arms (ODAs) and inner dynein arms (IDAs)
dock to the A tubule on the outer doublet and project towards the B tubule of the
neighboring outer doublet. Also attached to the outer doublet is the T-shaped radial spoke
(RS). It docks to the outer doublet with a thin stalk and projects a bulbous head toward
the CP. These axonemal structures of the 9+2 machinery appear at precise locations
relative to each other and at exact periodicities along the length of the axoneme. When
viewed longitudinally, four ODAs, three IDAs and two RSs are present in each 96-nm
register (Warner and Satir, 1974; Mastronarde et al., 1992, Nicastro et al., 2005, 2006).
Each projection has a distinct role but they operate in concert to generate oscillatory
beating.
It is well established that oscillatory beating of motile cilia and flagella is founded
on the inter-doublet sliding driven by dynein motors (Summer and Gibbons, 1971). ATP
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hydrolysis in the motor head induces conformational changes, leading to a power stroke.
The motor walks against the neighboring outer doublet towards the minus end, i.e. the tip
of the flagella. This conversion of chemical energy into physical force by the dynein
motor triggers the sliding between adjacent outer doublets (Lindemann and Lesich,
2010). The static linkers like nexin between outer doublets convert this sliding into bend
formation. In theory, alternate sliding of opposing outer doublets is the foundation of
oscillatory beating (Smith and Yang, 2004).
In contrast to the well characterized dynein motors and the dynein-driven sliding,
the control of this sliding is not well understood.

1.3 Proposed Roles of RS and CP
It is apparent that the thousands of dynein motors distributed in each of the 9 outer
doublets and along the length of the axoneme must take turns undergoing the power
stroke in order to alternate inter-doublet sliding, generate bends and thus oscillatory
beating. If all of the motors became activated simultaneously, there would be no net
movement and the flagella would become paralyzed. Such paralysis has been observed in
Chlamydomonas mutants as well as human patients, due to deficiencies in the RS or the
CP (Witman et al., 1978; Zariwala et al., 2007; Castleman et al., 2009). Independent lines
of evidence suggest that the RS and the CP constitute a system that determines which
subsets of motors become activated and which sets of outer doublets undergo sliding.
Studies of suppressor mutations of the paralyzed RS and CP mutants have found
that mutations in dynein motors and a group of 6 proteins adjacent to the motors can
partially rescue the paralysis of RS and CP mutants without restoring either structure.
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A

B

Figure 1-1. Cross sectional view of 9+2 axoneme.
(A) Electron microscopy of Chlamydomonas axoneme and (B) the schematic
representation. The scale bar represents 100 nm.
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Therefore, these 6 proteins were referred to as the dynein regulatory complex (DRC)
(Huang et al., 1982; Porter et al., 1994; Piperno et al., 1992, 1994). These results led to a
well-accepted model that the RS and the CP constitute a system to control dyneins
through the DRC. In theory, without the RS or the CP, dyneins are inhibited and
suppressor mutations in the dynein motors and DRC bypass this inhibition and restore the
motility.
Despite the paralysis of the RS and CP mutants, these two prominent features in
the 9+2 axonemes are not required for motility. Certain cilia, like nodal cilia are motile
inspite of their 9+0 axonemal arrangement (Nonaka et al., 1998). These cilia beat with a
very shallow waveform and at a low frequency, contrary to the planar waveform and high
frequency beating characteristic of 9+2 axonemes (Okada et al., 1999). Similarly, the
suppressor mutants exhibit a symmetric flagellar waveform unlike the asymmetric
waveform of wild-type cells (Omoto et al., 1996; Brokaw et al., 1982). Thus it was
postulated that the RS/CP control system overrides the rudimentary machinery, primarily
composed of 9+0 outer doublets and motors (Kamiya, 2002) and confers the high
frequency, asymmetric waveform characteristic of most cilia and flagella. This
dissertation investigates molecular interactions that underlie the assembly and the
mechanism of the RS.

1.4 The Radial Spoke
1.4.1 Radial spoke: The Mechanochemical Signal Transducer
The radial spoke is in position to directly activate dynein motors. The base of the RS is
near IDAs. Furthermore, electron microscopy of cilia that were instantaneously fixed
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while beating showed that the radial spoke is a mobile element similar to dynein motors
and the CP. It undergoes cycles of attachment and detachment with the CP. This
conclusion was founded on the observation that the RSs at the bend of the flagella tilt and
lengthen slightly (Warner and Satir, 1974; Goodenough and Heuser, 1985; Curry and
Rosenbaum, 1993). Also, in most motile cilia, during oscillatory beating the central pair
apparatus rotates once per beat (Tamm and Tamm, 1981; Omoto et al., 1999). It was
postulated that the tensio0n or force experienced by the RS from the rotating central pair
and sliding outer doublets activates subsets of dynein motors (Omoto et al., 1999).
The radial spoke is also implicated in the modulation of oscillatory beating. The
beating of all cilia and flagella is sensitive to common second messengers like calcium
and cNMP (Smith and Yang, 2004). These second messengers induce changes in the
beating partly through phosphorylation (Tash et al., 1989). For instance, calcium
concentrations affect the flagellar waveform. At 10-8 M calcium, the reactivated
axonemes beat with a highly asymmetric waveform which allows the cells to swim
forward. When the concentration increases to 10-4 M, the movement switches from
asymmetric to symmetric waveform, enabling cells to swim backward (Bessen et al.,
1980; Kamiya and Witman, 1984). As the suppressor of RS mutant exhibits symmetric
flagellar waveform, it was proposed that the RS is required for the generation of
asymmetric waveform at low calcium concentrations (Brokaw et al., 1982). A study
using microtubule-sliding of axonemes from the RS mutants also implicates the RS in
calcium-induced changes in motility (Smith, 2002).
In addition, it was proposed that dynein activity is inhibited by kinases and the RS
in the WT axoneme operates to inhibit the kinases. While the flagella lacking the RS are
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paralyzed, the axonemes can still undergo sliding. However, the sliding velocity is
reduced to half that of the WT flagella. The sliding velocity was restored to WT levels if
inhibitors for cAMP-dependent protein kinases and casein kinases were present (Howard
et al., 1994; Yang and Sale, 2000). On the other hand, inhibitors for phosphatases, PP1
and PP2A reversed the effects of the kinase inhibitors (Habermacher et al., 1996; King
and Dutcher, 1997; Yang and Sale, 2000). Thus it was proposed that the kinases inhibit
dynein motors and the RS operates to eliminate this inhibition.
Together, the evidence from genetic and functional studies supports a model that
the radial spoke regulates flagellar beating as a mechanochemical signal transducer.

1.4.2 Radial Spoke Composition
The composition of the RS was first revealed indirectly by the studies of Chlamydomonas
mutants. Electron microscopy shows that the flagella of pf14 mutants lack the entire RS
complex (Witman et al., 1978). The compositional analysis demonstrated that the
morphological phenotype correlated with the absence of 17 proteins. Thus it was
concluded that the T-shaped complex is composed of at least these 17 polypeptides,
referred to as radial spoke proteins (RSPs) (Piperno et al., 1977, 1981) (Figure 1-2).
Using dikaryon cytoplasmic complementation and revertant mutagenesis, it was found
that the phenotype is caused by a mutation in the RSP3 gene. Comparison of RSPs in the
axonemes from the spoke-less mutants and the mutants lacking only part of the RS
predicts that the bulbous spoke head consists of five proteins (RSP1, 4, 6, 9 and 10). The
rest of the proteins are proposed to be located in the spoke stalk (Piperno et al., 1977;
Huang et al., 1981). Based on the RSP2 mutant pf24, the stalk proteins, RSP2, RSP16
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and RSP23 are predicted to be located underneath the spoke head in a subcomplex
referred to as the spoke neck complex. In the pf24 axoneme, RSP2, RSP16, RSP23 and
spoke head proteins are less abundant, while the remaining spoke stalk proteins appear
normal (Huang et al., 1981; Patel-King et al., 2004; Curry and Rosenbaum, 1993). These
predictions are further supported by selected loss of RSPs by low salt dialysis (Piperno et
al., 1981) and by chemical crosslinking (Kohno et al., 2011). This arrangement is related
to the questions addressed in this dissertation.
Consistent with the genetic evidence, the 17 RSPs are present in an isolated radial
spoke that sediments as a 20S particle in a sucrose gradient. The 20S RS also contains 5
more molecules. Among the five, three molecules, IP2,3 and 4, form a complex that
associates with the RS and may be involved in anchoring the RS to the outer doublets
(Dymek et al., 2007; 2011). The other two are LC8 and calmodulin, the calcium sensor
(Yang et al., 2001; Patel-King et al., 2004). This finding supports the notion that the
radial spoke is involved in calcium induced motility changes. As these two molecules are
present in multiple axonemal complexes, they were not absent from the spoke mutants,
they were only recognized as RSPs following purifications of the RS.
Through multiple independent approaches, the genes encoding most molecules
were identified. Their amino acid sequences and predicted molecular domainss were
determined (Williams et al., 1989; Curry et al., 1992; Patel-King et al., 2004; Yang et al.,
2004; Yang and Yang, 2006; Yang et al., 2006; Dymek et al., 2007). Interestingly,
molecular modules related to signal transduction are located exclusively in the
spokestalk, while the spokehead primarily consists of structural proteins. In particular,
two stalk proteins, RSP7 and RSP11 contain a RIIa domain that is also present in PKA.
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Curiously, two molecules, RSP2 and RSP23 contain a Dpy-30 domain that resembles the
RIIa domain. In addition, these four molecules also contain calcium-binding motifs and
calmodulin-binding domains (Yang et al., 2006). This dissertation study reports the
discovery that RSP3 is the key molecule that integrates these RSPs with distinctive
molecular modules.

1.4.3 RSP3
1.4.3.1 RSP3: Sequence and Homology
Independent lines of evidence have shown that RSP3 plays multiple roles in the RS. One
striking feature of RSP3 is its sequence homology. RSP3 orthologues from various
organisms, ranging from Chlamydomonas to humans, share a higher homology than most
components unique to axonemes (Gaillard et al., 2001). All RSP3 orthologues contain the
highly conserved N terminal 320-a.a. (amino acid) region. Chlamydomonas RSP3 has an
additional ~200 a.a at the C-terminus, while a mammalian alternative-spliced isoform has
a ~100 a.a. extension at the N-terminus (Jivan et al., 2009). This high sequence homology
of the 320 a.a. residues implies a strong evolutionary pressure to maintain a key function.

1.4.3.2 RSP3 Docks the RS to the Axoneme
RSP3 is essential for the assembly of the RS (Luck et al., 1977; Piperno et al., 1981). The
RSP3 gene in the pf14 mutant has a premature stop codon near the translation initiation
site. Translation initiated from a downstream ATG produces diminished amounts of
truncated RSP3 polypeptides that fail to assemble into the axoneme (Williams et al.,
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HEAD

NECK

STALK

BASE

Figure 1-2. Radial spoke proteins and their predicted functional domains.
The radial spoke proteins are arranged based on their predicted locations. The Dpy-30
domain and RIIa domains are highlighted in red and green boxes respectively. MN,
MORN domain; DPY, Dpy-30 domain; GAF, cyclic GMP Adenylyl cyclase FhlA
domain; CAM, calmodulin binding motif; AKAP, A-Kinase Anchoring Protein; IQ,
calmodulin binding motif; NDK, Nucleoside Diphosphate Kinase domain; DnaJ and
DnaJ-C, molecular chaperone homology domains; RIIa, RII alpha domain; EFH, EF-hand
domain; PPI, Peptidyl Prolyl Isomerase domain; LRR, Leucine Rich Repeat domain.
Coiled coil regions are depicted by open bars. This figure was modified from Yang et al.,
2006.
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Table 1-1. Chlamydomonas radial spoke mutants that are relevant to this
dissertation
Mutants

Motility
phenotype

Morphological
Defect

Gene
product

Protein
missing
All spoke
proteins

RSPs in
reduced amount

Predicted
location

pf14

Paralyzed

Spokeless

RSP3

NA

Base

pf24

Paralyzed

Less spokeheads
and stalks

RSP2

None

1,4,6,9,10,2,16,23

Neck

pf25

Swimming/Paralyzed

None

RSP11

11

8

Base
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1989), leading to spoke-less axonemes in pf14. The importance of the N-terminus is
clarified by a reconstitution experiment. Reconstitution of axonemes and recombinant
RSP3 synthesized in rabbit reticulocyte lysate showed that RSP3 binds to the axoneme.
The binding site is confined to the N-terminal 85 a.a.. In parallel, expression of truncated
RSP3 from a cDNA minigene construct also showed that the N-terminus of RSP3 is
required for rescuing the motility of pf14 while the C-terminus is dispensable (Diener et
al., 1993). Based on these results from in vitro and in vivo experiments, it was proposed
that RSP3 is located at the base of the RS for anchoring the entire RS to outer doublets.
The function of the rest of the conserved region is unknown.

1.4.3.3 RSP3: A Homodimer
Chemical crosslinking of isolated axonemes showed that RSP3 exists as a homodimer in
the RS. The axoneme-binding region is capable of dimerization (Wirschell et al., 2008).
It is speculated that this stable homodimer forms the scaffold at the base of the RS onto
which other RSPs assemble. The results from this dissertation show that the dimeric
RSP3 is a scaffold extending throughout the RS, not just at the base, which directly
interacts with key RSPs.

1.4.3.4 RSP3: The Spoke AKAP
RSP3 is currently referred to as an A-kinase anchoring protein (AKAP). From a historic
perspective, the key role of AKAPs is to anchor the cAMP dependent protein kinase
(PKA) (Pidoux and Tasken, 2010). PKA is a tetrameric holoenzyme with two catalytic
subunits and two regulatory subunits, RI or RII (Figure 1-3). It is the primary effector for
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the cAMP signal transduction pathways (Logue and Scott, 2010). Like the ubiquitous
second messenger, cAMP, many AKAPs have been identified in various intracellular
compartments. They differ drastically in their size and sequence. Yet they all have
several common properties (Welch et al., 2010) (Figure 1-3). First of all, they all contain
a ~14-18 a.a. amphipathic helix (AH) that interacts with the 40-a.a. dimerization and
docking domain (D/D), RIIa, in the regulatory subunit, either RI or RII isotypes of PKA
(Carr et al., 1991) (Figure 1-3 and 1-4). It is this very interaction that localizes PKA. In
addition, all AKAPs contain a site that binds to a particular intracellular compartment,
such as the cytoskeleton, mitochondria or Golgi (Wong and Scott, 2004). Lastly, they
also contain additional motifs for binding to various molecules critical for different signal
transduction pathways such as phosphatases and other kinases (Klauck et al., 1996;
Welch et al., 2010). Thus it was proposed that AKAPs localize this enzyme of broad
substrate specificity near its intended target proteins. The binding of cAMP to the
regulatory subunit leads to the release and activation of the catalytic subunits which in
turn phosphorylate the adjacent substrate (Figure 1-3). Presumably the anchoring of PKA
through AKAPs improves the precision and efficiency of cAMP mediated signal
transduction (Scott and Pawson, 2009). Furthermore, by anchoring PKA along with other
molecular switches which may be synergistic or antagonistic, the different signal
transduction pathways can be integrated (Figure 1-4 A).
Initially, anchoring proteins of PKA were identified based on their co-purification with
PKA (Lohmann et al., 1984; Vallee et al., 1981). The interaction was mapped to the RIIa
domain in the regulatory subunit (Scott et al, 1990) and an AH in AKAPs (Carr et al.,
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A

B

Figure 1-3. The tetrameric holoenzyme of cAMP-dependent protein kinase.
(A) The functional domains in the regulatory and catalytic subunits of PKA. The
regulatory subunit contains an N terminal docking and dimerization domain
known as the RIIa domain; two cAMP-binding sites and an auto-inhibitory site
that binds the catalytic subunit and blocks catalysis. The catalytic subunit contains
an ATP binding site, a substrate binding site and a regulatory subunit binding site.
(B) The mechanism of PKA. The PKA tetramer contains two regulatory subunits
(grey boxes) and two catalytic subunits (blue circles). The holoenzyme is inactive
until cAMP (orange circles) occupies the cAMP binding sites in the regulatory
subunit. This releases the active catalytic subunits (red circles) which
phosphorylate the substrates.
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A

B

Figure 1-4. AKAPs: The signaling scaffolds and their interaction with the RIIa
domain.
(A) Schematic showing three main features of an AKAP: a targeting domain that
anchors an AKAP to a specific subcellular location; an amphipathic helix (yellow) that
binds to the RIIa domain of PKA (pink and purple) and additional sites that binds
other signaling molecules. RII, regulatory subunit; C, catalytic subunit. (B) Crystal
structure of RIIa domain (blue and pink helices in complex with AKAP (yellow). This
structure is modified from PDB ID: 2IZY (Gold et al., 2006).
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1991). Most AKAPs were identified using an overlay using radioactive RII as a ligand
(Lohmann et al., 1984). This assay was used to screen expression libraries or protein
blots. The binding is blocked by AHs with high affinities for the dimeric RIIa (Carr et al.,
1992; Alto et al., 2003; Burns-Hamuro et al., 2003). Many proteins were found to bind
RII in vitro, and thus they were referred to as AKAPs and presumed to anchor PKA in
vivo. The micro-compartments that they are located in are presumed to be regulated by
PKA. Similarly, the RI regulatory subunit of PKA is also used in overlays. Based on the
affinity and specificity of AKAPs for RI or RII, AKAPs are classified into three
categories, RI-AKAP that interacts with RI alone; RII-AKAP that interacts with RII
alone; and dual AKAP (D-AKAP) that interacts with both RI and RII.

1.5 The RIIa Clan
While the AH-RIIa interaction was exploited to identify the PKA anchoring proteins,
AKAPs, the RIIa domain has been found in many proteins that are irrelevant to PKA. In
fact, this domain is present in more than 200 molecules with diverged molecular
architectures in various eukaryotic genomes. Most of them are poorly characterized. Two
such molecules are in the radial spoke complex of Chlamydomonas flagella, RSP7 and
RSP11 (Yang and Yang, 2006; Yang et al., 2006). Furthermore, a RIIa-like domain, Dpy30, was found in equally numerous poorly characterized molecules, including two
proteins in the radial spoke complex, RSP2 and RSP23 (Yang et al., 2006). These
proteins with either a RIIa or Dpy-30 domain are classified into two subfamilies within
the RIIa clan in the protein family database Pfam (Table 1-2).
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1.5.1 RIIa Clan Domains
RIIa and Dpy-30 domains share considerable similarities in sequence, secondary
structure and tertiary structure. However, they also have significant distinctions that
define the two domains.

1.5.1.1 RIIa Domain
The RIIa domain is usually 40-a.a. long. RIIa domains share extensive sequence
homology, except the N-terminal region. The core is comprised of a helix-loop-helix
secondary structure (Newlon et al., 1999 and 2001). Structural studies have primarily
focused on RII’s RIIa domain. The structures showed that two helix-loop-helix
monomers fold into a X-type four helix bundle (Gold et al., 2006; Kinderman et al.,
2006) (Figure 1-4). The dimerization forms a shallow groove that binds to the AH in
various AKAPs. The lateral boundary was defined by a β-strand from the N-terminus
(Kinderman et al., 2006).
The interaction of the dimeric RIIa and the AH is primarily hydrophobic in
nature. The hydrophobic residues in the groove of the RIIa dimer, including the β-strand,
associate with the hydrophobic residues clustered on one side of the amphipathic helix.
More recent structures of RI’s RIIa domain in complex with an AH also revealed a
similar X-type four-helix bundle (Banky et al., 2003; Sarma et al., 2010). However, the
N-terminus unique to RI’s RIIa is helical, contrary to the β-strand in RII’s RIIa. The
additional helix folds inwards, resulting in a much deeper hydrophobic, AH-binding
cavity (Banky et al., 2003; Sarma et al., 2010).
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1.5.1.2 Dpy-30 Domain
In contrast to the RIIa domain, the study of the Dpy-30 domain is relatively nascent.
Dpy-30 in C.elegans was the first Dpy-30-domain containing protein discovered. The
name was derived from the dumpy phenotype of the mutant nematode defective in the
encoded gene. Genetic analyses revealed that the protein is part of the chromosome
modification complex. It not only affects the body shape but is also involved in Xchromosome dosage compensation (Hsu et al., 1994). Studies in other organisms revealed
that the Dpy-30 protein is also a small yet critical subunit in various Set1- like histone
methyltransferase complexes that mediate epigenetic regulation in most eukaryotic cells
(Roguev et al., 2001; Cho et al., 2007; Patel et al., 2009). In embryonic stem cells,
depletion of Dpy-30 blocks the neuronal differentiation (Jiang et al., 2011). A 40-a.a
region in this ~100-a.a. Dpy-30 ortholog shares limited sequence homology with the RIIa
domain in PKA (Roguev et al., 2001). As more genome sequencing projects were
completed, sequences with homology to this region were found in many divergent
proteins. The sequences associated with this conserved domain vary drastically. Thus this
conserved motif was named the Dpy-30 domain.
Analogous to the RIIa domain, this new domain is also composed of a helix-loop-helix
secondary structure. However, this common unit in all Dpy-30 domains is preceded by a
short helical sequence that is absent in RII’s RIIa domain (Wang et al., 2009) (Figure 14). The recently solved X-ray crystal structure of this domain from the human Dpy-30
protein also forms an X-type four-helix bundle. The N-terminal helix occupies the
position of the β-strand in RII’s RIIa domain. The cavity in the dimer is deeper and less
hydrophobic than RII’s RIIa domain (Wang et al., 2009). Numerous AHs that bind the
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Table 1-2. The RIIa-clan members
The RIIa clan consists of two subfamilies, RIIa and Dpy-30. The RIIa clan
domain containing proteins listed above are classified based on the functional
modules associated with the RIIa clan domain. RIIa, RII alpha domain; GK,
Guanylate Kinase domain; ADK, Adenosine Diphosphate Kinase domain;
NDK, Nucleoside Diphosphate Kinase domain; Dpy-30, Dpy-30 domain; IQ,
calmodulin binding motifs; EF, calcium binding EF hands; cNMP, catalytic
subunit of proteins kinase A; CaMB, calmodulin binding motif.
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A

B

Figure 1-5. Crystal structures of the RIIa clan domains.
(A) The RIIa domain from RII (PDB ID: 2HWN, Gold et al., 2006) and (B) the
Dpy-30 domain from the human Dpy-30 protein (PDB ID: 3G36, Wang et al.,
2009).
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RIIa domain have been discovered and two sequences in Ash2 of the histone
methyltransferase complex and BIG1 GTPase exchange factor in the Golgi apparatus
were found to bind Dpy-30 protein during the period of this thesis (South et al., 2010; Xia
et al., 2010). The common feature among Dpy-30 binding sequences remains uncertain.
The similarity of these D/D domains and the numerous proteins with these
domains begs an important question about the specificity. How do these similar domains
dock these important proteins to the appropriate locations: PKA to the cAMP-signaling
sites, Dpy-30 to the histone methyltransferase complex and BIG1 GTPase exchange
factor to the Golgi? What are the other functions that these similar D/D domains may
dock?

1.5.1.3 RII- Clan-Domain Containing RSPs
These questions can be elucidated by investigating the RS. The RS contains an AKAP
that binds PKA’s RII in vitro (Gaillard et al., 2001). Instead of PKA, the RS also harbors
four non-PKA RIIa clan members. RSP7 and RSP11 have RIIa domains; and RSP2 and
RSP23 have Dpy-30 domains (Yang et al., 2006). All four proteins are in the stalk.
Consistent with the docking function of the domains, genetic evidence suggests that the
paired RIIa-containing RSPs and Dpy-30-containing RSPs are located at opposite ends of
the stalk. It is unclear how these four molecules with a similar D/D domain dock onto the
different parts of the small RS complex and contribute to its role in mechanochemical
regulation.
The RSP2 mutant, pf24, generates paralyzed flagella due to an initiation codon
mutation in the gene encoding RSP2 (Huang et al., 1981; Yang et al., 2004). The
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axoneme has diminished amounts of RSP2 protein, the spoke HSP40 and Dpy-30containing RSP—RSP23, while the spokehead components are reduced, albeit less
drastically (Huang et al, 1981; Patel-King et al., 2004). Thus it was predicted that Dpy-30
domain containing RSP2 and RSP23 are co-assembled along with RSP16 near the neck.
Note that the deficiency of the spoke head is less severe than that of RSP2, indicating that
RSP2 is only one of the molecules linking the spoke head to the spoke stalk.
It was recently shown that the assembly of RSP2 to the RS is mediated by the
Dpy-30 domain and the trailing coiled coil. The calmodulin binding motifs within the C
terminal region of RSP2 also suggest that RSP2 is involved in regulating flagellar beating
(Gopal et al., unpublished). The additional sequence in RSP23 contains a NDK domain
that converts NDP to NTP. Consistent with this, the RS contributes to a fraction of the
NDK activity in the axoneme. The role of this NDK domain remains to be determined.
The two RIIa-containing RSPs appear normal in the pf24 axoneme and thus they
are predicted to be located away from the neck region. The sequences tethered to the RIIa
domain are equally intriguing. A series of calcium-binding EF hands trail the RIIa
domain in RSP7. The additional sequence in RSP11 is devoid of any molecular domains.
RSP11 is not essential for the assembly of the RS or for motility (Yang and Yang, 2006).
Mutants lacking RSP11 generates motile flagella only when the media is fresh and
enriched. The flagella become paralyzed when the media is exhausted of nutrients in the
stationary phase. The mutant also displays reduced levels of RSP8, another RS subunit
with armadillo (ARM) repeats known for protein-protein interactions (Yang et al., 2006).
This suggests that RSP8 and RSP11 interact. However, the nature of the association of
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these two proteins and why deficiencies in these two proteins result in reversible
paralysis is unclear.
Although RII, RSP7 and RSP11 all have the RIIa domain, mutations of the AH in
RSP3 abolished only the interaction of RSP3 with RII in the overlay assay (Gaillard et
al., 2006). The same mutation when introduced into Chlamydomonas, caused a mixed
population of swimmers and immotile cells (Gaillard et al., 2006) but the amount of the
RIIa-domain containing proteins, RSP7 and RSP11, was not reduced (Gaillard et al.,
2006). These inconsistencies raise several questions. Does the amphipathic helix serve to
anchor PKA to the RS; or the non-PKA RIIa-containing RSP7 and RSP11? If it does
anchor these two RSPs, why are they still assembled when the amphipathic helix is
perturbed? What molecules do the Dpy-30 domain in RSP2 and RSP23 interact with and
what are their sequences? The answers to these questions will reveal the topology of the
RS and help to understand how RS regulates flagellar beating mechanically and
chemically. Importantly, the answers could elucidate the mechanisms that distinguish the
specificity of these two similar RIIa clan domains and the effector mechanisms that tether
to these putative D/D domains.

1.6 Objectives of the Research
Objective 1: Test the hypothesis that the spoke AKAP, RSP3, forms the backbone of
the radial spoke stalk.
We reason that the arrangement of the four RSPs with the RIIa clan domains must
provide the predicted rigidity necessary for RS to couple the mobile CP and the outer
doublets at high frequency (Warner and Satir, 1974). The simplest model is that all four
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molecules anchor to the dimeric RSP3. As RSP2 and RSP23 are located near the
spokehead and the RSP3 N-terminus binds to the axoneme, this prediction implies that
RSP3 forms the spoke scaffold, extending throughout the RS complex. Chapter 3 is
focused on testing this hypothesis. To test this hypothesis, truncations were made within
RSP3. The flagella of the mutant strains were analyzed for their composition and
morphology. We predict that deleting the binding sites for the RIIa domain or for the
Dpy-30 domain shall result in deficiencies in the four RSPs, either in their composition or
their stability. Electron microscopy studies on some of these mutants showed that
truncating RSP3 results in a dwarfed radial spoke stalk which is consistent with RSP3
forming the RS scaffold. This work is described in Section I of Chapter 3.
Objective 2: Identify the binding sites for the RIIa domain and the Dpy-30 domain
in the RS
Once the binding proteins and the binding regions were identified in vivo, an in vitro
approach was taken to define the binding sequence. The binding sequence and the D/D
domains were co-expressed in bacteria for testing their interaction by co-purification.
Once the binding sequence for the Dpy-30 domain was identified, sequence analyses
were conducted to determine the similarity and distinction of the binding sequences for
the RIIa and the Dpy-30 domains. This work is described in Section II of Chapter 3.
Objective 3: Develop tools to study the RIIa domains and Dpy-30 domains.
The study of Dpy-30 domains is still emerging. Many Dpy-30 domain containing
proteins and their anchoring proteins are poorly characterized. Even the Dpy-30 domain
in the Dpy-30 protein, is known to anchor at least two molecules, Ash2 in the histone
methyltransferase complex and BIG1 in the Golgi apparatus (South et al, 2010; Xia et al.,
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2010). It is likely that more Dpy-30-anchoring proteins remain to be discovered. In
addition, the similarity of the anchoring sequences discovered in this dissertation raises
question about the distinction in the specificity, affinity and kinetics of the two types of
D/D domains. This dissertation developed alternative reagents and assays to address these
questions. This project is described in Chapter 4.
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Chapter 2: Materials and Methods
The chemicals, biological reagents, molecular biology, cell biology and protein
biochemistry methods used in this study are outlined in this chapter.

2.1 Materials
2.1.1 Chemical Reagents
Chemical reagents used in this study are summarized in Table 2-1.
2.1.2 Oligonucleotides
Oligonucleotides used in this study for polymerase chain reactions (PCR) to engineer
plasmids and truncation mutants are listed in Table 2-2.
2.1.3 Antibodies
The antibodies used in this study are listed in Table 2-3.
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Table 2-1. Chemicals used in this study
Vendor

Name

Amresco

Bio-Rad

Yeast Extract
Dithiothreitol (DTT)
Isopropyl-β-D-thio-galactoside (IPTG)
Acrylamide

Biolab Inc.

dNTPs

Calbiochem

Nonidet-P40

Celliance

Aprotinin

EM Sciences

Osmium Tetroxide
Propylene oxide
2,4,6-(Tri(Dimethylaminoethyl)phenol) (DMP30)
Dodecenyl succinic anhydride (DDSA)
Nadic methyl anhydride (NMA)
EMBed-812
Uranyl Acetate
Urea
Methanol
Potassium hydrogen phosphate (K2HPO4)
Potassium dihydrogen phosphate (KH2PO4)
Tris Base

Invitrogen
JT Baker

Fisher Scientific
Mallinckrodt
Midwest Sci.

Potassium iodide
Sucrose
Agarose
Tryptone

MP Biomedicals
Polysci Inc.
Shelton Scientific
Spectrum Chemical

Paromomycin
Sodium Cacodylic acid
Bromophenol blue
Dibucaine

Stratagene

Pfu DNA polymerase

TCI America

Luminol
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Sigma

Acetic acid
Agar
Ammonium chloride (NH4Cl)
Ammonium persulfate
Ammonium nitrate (NH4NO3)
Boric acid (H3BO3)
Bovine Serum Albumin (BSA)
Calcium Chloride dehydrate (CaCl2.2H2O)
Cobalt Chloride hexahydrate (CoCl2.6H2O)
Coumaric acid
Cupric sulfate pentahydrate (CuSO4.5H2O)
L-Cysteine
Ammonium heptamolybdate ((NH4)6Mo7O24)
Dimethyl Sulfoxide (DMSO)
Ethidium Bromide
Ethylenediaminetetraacetic acid (EDTA)
Ethylene glycol tetraacetic acid (EGTA)
Ferrous sulfate (FeSO4.7H2O)
Glycerol
Glycine
Glutaraldehyde
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hepes)
Hydrogen peroxide (H2O2)
Imidazole
Kanamycin
β-mercaptoethanol
Manganese sulfate (MnSO4)
Manganese chloride (MnCl2)
Magnesium sulfate heptahydrate (MgSO4.7H2O)
Phenylmethanesulfonyl fluoride (PMSF)
Polyethylene glycol (PEG 8000)
Ponceau S
Potassium Acetate (KCH3COO)
Potassium chloride
Ribonuclease
Sodium Dodecyl Sulfate
Sodium chloride (NaCl)
Sodium Hydroxide (NaOH)
Sodium Acetate (NaCH3COO)
Sodium Carbonate (Na2CO3)
Sodium phosphate (NaH2PO4)
Sulfosalicylic Acid
Tannic acid
Tetramethylethylenediamine (TEMED)
Zinc sulfate heptahydrate (ZnSO4.7H2O)
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Table 2-2. Oligonucleotides used in this study
Name

Sequence

XbaS
XhoAS
XhoS
AS
SpeS
NotAS
EcoRIS
XbaAS1
XbaAS2

AGCTCTAGACTACTCTCAGCTTGAGCCACATTTATGC
TCTCCATCAGGCCCTGCTCGAGCACCTTGCCCAC
TCTCGAGCTGTCTGGCATTGTCAACACGGTG
TCTTGTCCGCCTCCCACTTGGCGTTG
CCGCAAGCTCACTCGTTCACCATAAAC
AGCGGCCGCGCGATTGGCTGCCAGCGCCGCCGC
GGAATTCCCGCTCTGCTCTCCAGTCCGACTAGGG
GCTCTAGACGCCAGGGTGCTGCGATTGGCTGCC
GCTCTAGAGCCGCGCGCAAAGGCGCTGGCCGCC

XbaAS3
XbaS(tag)
EcoRIAS
XhoS
ICAS
96BamS
180RIAS
245BamS
316RIAS
269BamS
NdeS
DpyHindAS
RSP2HindS
RSP2XhoAS

GCTCTAGACTCCTCCTCCTCCAGCACCTCCATCAGG
GCTCTAGACAGGCGCTGGCGGTGCACGCGCTGGG
GGAATTCTGTTGCCTGAGAGCTCCGCCTCGGCC
ACCTCGAGCACCACCACCACCACCACTAAGCTAGAGGG
ACCTCGAGGGGGTACGTAGATGTAGCCGCT
GCGGATCCCGGCACATCGACATCCAAACGGAC
CGGAATTCTTACTCCTCCAGCACCTCCATCAGGC
GCGGATCCGCCTTTGCGCGCGGCTACCTGTCTGGC
GCGAATTCGGTGCTGCGATTGGCTGCCAGCGCCGC
GCGGATCCCCCGTCATGCGCGAGGTGGAGACGG
CCCATATGGAGCCAGAGCAGATGCTGGAG
GCAAGCTTCTGGAGATCTACCTTCTGCTTTGATGAC
GCAAGCTTCCCGACACAGCCTACCTCAAAGAGAC
GCCTCGAGTCATTCTACTTCAGCATTTTTCACGTATTTGAGC

PstIS
NheIAS
NcoS
GSTAS
280BamS
306RIAS
298RIAS
308RIAS
HybridS
V*PS

GCTGCAGAAGGTAGATCTCCAGTCTTTGCCAAC
GGCTAGCTCAGTTTCGATCTTCAAACTGTGCC
GCCCATGGAGTCCCCTATACTAGGTTATTGG
GGGGGATCCACGCGGAACCAGATCCG
GCGGATCCCCCTGGCTCAAGGAGCAGG
GCGAATTCGTCCTCCACCAGCTTGTCCACC
GCGAATTCGCGCCGCGCCACCAC
GCGAATTCCGCCGCGTCCTCCACCAGCTTGTCC
GATCTGGTTCCGCGTGGATCCCCCTGGCTCAAGGAGC
GTGGCGCGGCGCGTGCCGGACAAGCTGGTGGAG
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V*PAS

CTCCACCAGCTTGTCCGGCACGCGCCGCGCCAC

H301BamS
H325RIAS
HHybS
AatIIS
AatIIAS

GCGGATCCGAAAAAACCATGGAATATAGCATGG
GCGAATTCCCTCTTTTCAACCACCTCACG
GATCTGGTTCCGCGTGGATCCGAAAAAACCATGGAATATAGC
GGACGTCGACGGCGGGGAGCTCGCTG
GGACGTCGGTACCCGCTTCAAATACGCC

S: Sense primer; AS: Antisense primer
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Table 2-3: Antibodies used in this study
Antigen
RSP1
RSP2
RSP3
RSP6
RSP7
RSP8
RSP11
RSP16
RSP23
IC140
HA
GST
Radial spoke

Host
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Mouse
Chicken

Reference
Yang et al., 2008
Yang et al., 2001
Yang et al., 2001
Yang et al., 2008
Yang et al., 2006
Yang et al., 2006
Yang et al., 2006
Yang et al., 2005
Yang et al., 2008
Yang and Sale, 1998
Covance Inc.,
Genscript
Yang et al., 2005

Secondary Antibodies
Anti-chicken IgY-peroxidase
Anti-rabbit IgG-peroxidase
Anti-mouse Ig –peroxidase

Rabbit
Goat
Goat

Sigma
Sigma
Sigma
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2.2 Cell Strains and Culture Conditions
The Chlamydomonas reinhardtii strains used in this study were wild-type strain cc124(-),
and paralyzed RSP3 mutant strain, pf14. They were obtained from the Chlamydomonas
Resource Center (Duke University, Durham, NC).
The cells were grown on Tris-Acetate-Phosphate (TAP) plates for 6-7 days.
Subsequently a loop of cells were inoculated into ~350 ml TAP liquid medium and
cultured under aeration in a 14/10 light/dark cycle (Harris, 2009).

2.3 Molecular Biology
2.3.1 Polymerase Chain Reaction-based DNA Fusion
To generate small (< 100 bp) truncation constructs a mixed PCR strategy was adopted.
For instance, to create a vector that expresses GST-RSP3280-308, GST and RSP3280-308
were amplified. The PCR fragments, 5 ng each, were used as the templates for the fusion
PCR reaction. They were amplified using three primers: GST forward primer; RSP3308
reverse primer and a hybrid forward primer that contains the 3’end sequence of GST and
5’end sequence of RSP3280-308. The resulting PCR product with both coding sequences
could be cloned into an expression vector using conventional cloning techniques. The
conditions used for the mixed PCR took into the consideration the annealing temperature
of all the three primers and DMSO was omitted from the PCR reaction. Other parameters
were not varied.

2.3.2 Engineering Genomic DNA Constructs
A NcoI fragment containing the RSP3 genomic DNA was released from a BAC clone
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Figure 2-1. The PCR strategy for fusing the sequences encoding a large tag and
a small amphipathic helix.
This method is developed to overcome the difficulty in cloning a small DNA
fragment for protein expression. The templates for PCR amplification include the
PCR fragments for GST and for RSP3’s AH. Three primers for PCR amplification:
the NcoS primer, the RSP3AS primer and the hybrid primer (HybS) which contain
the 3’ end sequence of GST DNA and the 5’ end sequence of RSP3’s AH. The PCR
product generated from this reaction is purified and inserted into pET-Duet vector
digested between the NcoI site and EcoRI site.
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and inserted into NcoI site in pGEM-T Easy vector (Promega). The SacI site and its
downstream sequence in the 3’ flanking region were eliminated by limited restriction
digest followed by treatment with T4 DNA polymerase. PCR with modified primers was
performed to add the sequence for 6 His codons flanked by XhoI site at one end and stop
codon followed by Xba site at the other end. Subsequently, a PCR product containing
3HA-6His coding sequence flanked by XhoI sites was ligated into the XhoI site. This
fragment was amplified using p3HA plasmid (Silflow et al., 2001) as a template. The
final RSP3 genomic construct, pRSP3-HAHis expressed a polypeptide with a 3HA and
12His tag. This construct was used to create all the mutant constructs. All the strains were
generated using a PCR based approach.
∆1
The nucleotide sequences flanking Coil1 (171-244 a.a.) were amplified from pRSP3HAHis vector using the following primer pairs: XbaS, XhoAS and XhoS, AS. The PCR
fragments were digested with XbaI and XhoI; and with XhoI and NotI. The two digested
fragments, i.e. Xba-Xho and Xho-Not, were ligated into pRSP3-HAHis vector digested
with SpeI and NotI. XbaI and SpeI generate complementary free ends that allow ligation
and distinction between the parental DNA and the ligated DNA. For single plasmid
transformation in Chlamydomonas, this construct was further modified by adding the
paromomycin (PMM) resistance cassette from pSI 103 plasmid (Yang et al., 2008) into
the AatII site. This vector is designated as p∆Coil1PMM.
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pRSP3-3HA-12His
Figure 2-2. Cloning Strategy for the generation of pRSP3-3HA-12His.
The pGEM T- Easy vector that contained the sequence encoding the RSP3 genomic
DNA (bold line) was amplified using primers with 6 His codons flanked by XhoI
site at one end and a stop codon followed by a Xba site at the other end. This PCR
fragment along with the Xba-SacI piece was ligated into the SacI site in the pGEM
T-Easy vector. The sequence encoding the 3 HA tag was amplified from p3HA
plasmid with primers that contained built in XhoI sites at both ends and also the
sequence for 6 His codons. The resulting fragment which contained the sequence for
3HA tag and 6 His codons flanked on either side by Xho I site was cloned into the
XhoI site thus generating pRSP3-3HA-12His.
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Figure 2-3. Strategy for the generation of RSP3 truncation constructs.
Schematic representing the cloning strategy that was applied to generate the
various RSP3 truncation constructs. The grey boxes represent the 5’ and 3’ UTR;
the black boxes depict the exons and the black lines depict the introns. The three
coils in RSP3 are shown as the colored boxes. The primer pairs utilized to
generate each construct are also depicted.
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∆2
The nucleotide sequences flanking coil2 were amplified from the pRSP3-HAHis vector
using SpeS and NotAS primers. The amplified fragment was ligated into p∆Coil1PMM
vector digested with Spe and Not.
The PMM cassette was also cloned into the AatII site in pGEM-T Easy, and this
vector (pGEM-T Easy + PMM) was used to generate the remaining RSP3 constructs.
1-178
To create the RSP31-178 construct, two fragments were amplified from the pRSP3-HAHis
vector. The first fragment which extended from the 5’UTR to 178 aa was generated using
a EcoRIS primer with a built in EcoRI site and an antisense primer (XbaAS3) with a built
in Xba site. The second fragment which extended from the 3HAHis tag to the 3’UTR was
generated using a sense primer with a built in Xba site (XbaStag) and an antisense primer
with a built in EcoRI site (RIAS). The two fragments (RI-Xba and Xba-RI) generated by
PCR were ligated into the pGEM-T Easy + PMM template digested with RI.
1-244
To create the RSP31-244 construct, flanking sequences were amplified using the same set
of primers that were used to make RSP31-178, except XbaAS3 primer was replaced with
the XbaAS2 primer, which resulted in a fragment extending from the 5’UTR to 244 aa.
The second fragment which extended from the 3HAHis tag to the 3’UTR was generated
using a sense primer with a built in Xba site (XbaStag) and an antisense primer with a
built in EcoRI site (RIAS). The two fragments (RI-Xba and Xba-RI) generated by PCR,
were ligated into the pGEM-T Easy + PMM template digested with RI.
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1-316
To create the RSP31-316 construct, flanking sequences were amplified using the same set
of primers that were used to make RSP31-178, except XbaAS3 primer was replaced with
the XbaAS1 primer which resulted in a fragment extending from the 5’UTR to 316 a.a.
The second fragment which extended from the 3HAHis tag to the 3’UTR was generated
using a sense primer with a built in Xba site (XbaStag) and an antisense primer with a
built in EcoRI site (RIAS). The two fragments (RI-Xba and Xba-RI) generated by PCR,
were ligated into the pGEM-T Easy + PMM template digested with RI.
1-269
To create the RSP31-269 construct, two fragments were amplified from the pRSP3-HAHis
vector. The first fragment which extended from the 5’UTR to 269 a.a. was generated
using the EcoRIS primer and ICAS primer with a built in Xho site. The second fragment
which extended from the 3HAHis tag to the 3’UTR was generated using a sense primer
with a built in Xho site and RIAS primer. The two fragments (RI-Xho and Xho-RI)
generated by PCR, were ligated into the pGEM-T Easy + PMM template cut with RI.

2.3.3 Engineering cDNA Constructs
i) GST-tagged RSP396-180; RSP3245-316 and RSP3269-316
The constructs expressing GST tagged RSP396-180, RSP3245-316 and RSP3269-316 were made
by first amplifying the corresponding sequences from GST-RSP3 cDNA as a template
(Diener et al.,1993) using a sense primer with a built in Bam site and an antisense primer
with a built in RI site. The PCR products were then inserted into pGEX-2T vector
digested with Bam and RI.
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ii) GST-tagged RSP3269-298
RSP3269-316 in pGEX-2T was used as the template. The sequence corresponding to
RSP3269-298 inclusive of the GST tag was amplified. The NcoS primer with a built in Nco
site annealed to the GST tag and the 298RIAS primer was used to amplify the RSP3
sequence. The resulting fragment which consisted of GST-RSP3269-298 was inserted into
pET-Duet vector (Novagen) digested with Nco and RI.
iii) GST- tagged RSP3280-316; RSP3280-306 and RSP3280-308
The constructs for expressing these short fragments were modified from the pGEXRSP3245-316. The PCR fusion strategy was employed to fuse the coding sequences for
GST and a RSP3 fragment. The fused PCR fragment was inserted into pET-Duet vector
digested with Nco and RI.
iv) RSP3280-316V300P
The pRSP3280-316 was used as the template to replace V300 into P using QuikChange
Site-Directed mutagenesis strategy (Stratagene). The resulting plasmid is named
pRSP3V300P.
v) His-tagged full length Dpy-30 (FL)
To create the His –tagged Human Dpy-30 full-length construct the sequence was
amplified from a commercially available cDNA clone using a sense primer with a built-in
NdeI site and an antisense primer with a built-in XhoI site. The fragment was inserted
into pET-28a vector digested with NdeI and XhoI. The resulting construct expressed Nterminally- tagged Dpy-30.
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vi) His- tagged Dpy-3045-99
The Dpy-3045-99 construct expresses the Dpy-30 domain in the Dpy-30 protein. The
sequence was amplified using a sense primer with a built-in PstI site and an antisense
primer with a built-in NheI site. The PCR fragment is inserted into a modified pET-28a
vector that has a coding sequence for TEV protease cleavage site inserted downstream to
8 His codons, pET28a-H8-TEV (kindly provided by Dr. St.Maurice).
vii) GFP- tagged Ash2
The coding sequence for Ash2’s AH was PCR-amplified from a human cDNA clone
obtained from Open Biosystems. GFP sequence was amplified from a plasmid obtained
from Lechtreck and Witman (2009). The PCR products were fused together using the
PCR fusion strategy and cloned into the PstI site in the pET28a-H8-TEV vector.

2.3.4 Transformation of Chlamydomonas
All genomic constructs were transformed into the RSP3 mutant strain, pf14 using the
glass beads method (Kindle, 1990). Cells were grown in ~350 ml TAP media under light
and dark cycle to a mid-log phase and for an additional 24 hours under constant light.
The cells were spun down at 1,500 rpm for 5 minutes and treated with autolysin at a
concentration of 1x107 cells/ml until > 50% of the cells were lysed by 0.5% Nonidet-P40.
The autolysin-treated cells were washed with TAP medium and resuspended in the same
solution to a final concentration of 1 × 108 cells/ml. Aliquots of 300 µl cells were added
into each tube. Glass beads, 1-3 µg plasmids and 100 µl freshly prepared 20% PEG 8000
were then added to the tubes, followed by vortexing for 45 sec at speed 8 (Mini Vortexer,
VWR). Afterwards, 10 ml TAP media was added into the tube immediately. The cells
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were spun down gently in IEC clinical centrifuge at #3 setting for 5 min and resuspended
in fresh TAP media (5 ml) and recovered under light overnight. The next day the cells
were spun down again and the pellet was resuspended in 500 µl TAP and plated on TAP
agar plates with 10 µg/ml PMM. Individual colonies became visible in 5 days. The
colonies were re-streaked onto a fresh TAP plate.

2.4 Cell Biology
2.4.1 Microscopic Screening of Transformants
A small fraction of the growth from single colonies was resuspended in TAP medium or
water (200 µl) in 96-well plates for motility analysis using the inverted compound
microscopes (Olympus IX51).

2.4.2 Electron Microscopy
Purified axonemes were spun down at 15,000 rpm for 20 minutes in a microfuge. The
supernatant was discarded and the pellet was fixed with the primary fixative (25%
glutaraldehyde and 10% tannic acid/0.2 M cacodylate buffer, pH 7.4) for 1 hour on ice.
The primary fixative was discarded and the pellet was washed twice for 5 minutes each
with 0.1 M cacodylate buffer. After washing, the pellet was fixed with the secondary
fixative (4% osmium tetroxide/0.2 M cacodylate buffer, pH 7.4,) for 1 hour at room
temperature. After two washes, 5 minutes each, with 0.1 M cacodylate buffer, the pellet
was dehydrated sequentially with 50, 70, 80, 95 and 100% ethanol. The pellet was then
transferred to a glass vial containing 10:1 ratio of epoxy resin mixture (EMBed 812, 20
ml; DDSA, 9 ml; NMA, 12 ml; and DMP30, 0.62-0.82 ml) and propylene oxide. The
resin was allowed to infiltrate the pellet for 24 hours at room temperature. The pellet was
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transferred to a glass vial containing fresh epoxy resin and incubated at 60°C under
vacuum for 48 hours. The blocks were sectioned, stained and the images were taken as
described (Yang et al., 2008). The blocks were prepared by us while the sectioning and
images were taken by our collaborators at Oklahoma State University.

2.5 Biochemistry
2.5.1 Screening of Transformants: Flagella Miniprep
The growth from one re-streaked single colony was resuspended in 1 ml TAP media and
plated on a TAP plate. After 5-6 days of growth, the cells were recovered and
resuspended in 1 ml water containing 5.44 mM CaCl2. The resuspended cells were placed
under light for about 1-2 hours to allow hatching and flagella generation. The cells were
spun down at 1,500 g for 10 minutes (Sorvall RC6+, Thermo Scientific). The pellet was
resuspended in 5 ml HMDS (10 mM Hepes, 5 mM MgSO4, 1 mM dithiothreitol and 4%
sucrose) solution and 0.013 mM dibucaine was used to deflagellate the cells. The cells
were spun down at 1,500 g for 10 minutes and the flagella-containing supernatant was
collected. A 25% sucrose cushion in HMDS was added to the supernatant and centrifuged
at 1,500 g for 7 minutes (Clinical centrifuge, IEC, Swinging bucket rotor). The
supernatant was centrifuged at 13,000 g for 5 minutes. The pellet which contains the
flagella was resuspended in Buffer A (10 mM Hepes, 5 mM MgSO4, 1 mM
dithiothreitol, 0.5 mM EDTA, 30 mM NaCl, 0.1 mM PMSF, 0.5 TIU/ml Aprotinin, pH
7.4). The samples were fixed with 5X sample buffer for SDS-PAGE and were analyzed
by western blot.
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2.5.2 Extraction of Axonemal Proteins
Chlamydomonas cells were grown in ~ 350 ml TAP liquid medium for about three days
in 14/10 hour light and dark cycle. The cells were harvested by centrifugation at 1500 g
for 5 minutes (TA-10 rotor; Allegra 25R centrifuge; Beckman Coulter). The pellet was
resuspended in 20 ml HMDS solution (10 mM Hepes, 5 mM MgSO4, 1 mM
dithiothreitol and 4% sucrose). The cells were deflagellated using 50 mM dibucaine (1
ml/ L cell culture) followed by the addition of protease inhibitors, including 0.1 mM
PMSF, 0.5 TIU/ml aprotinin and 0.5 mM EGTA. The cell bodies were separated from the
flagella by centrifugation in a clinical centrifuge at speed #4 for 7 minutes. The
supernatant was underlayed with 5 ml 20% sucrose and centrifuged at 1500 g for 7
minutes (Clinical Centrifuge, IEC). The upper layer was centrifuged at 12,000 g for 10
minutes using TA-14 rotor; Allegra 25R centrifuge. The pellet containing flagella was
resuspended in Buffer A (10 mM Hepes, 5 mM MgSO4, 1 mM dithiothreitol, 0.5 mM
EDTA, 30 mM NaCl, 0.1 mM PMSF, 0.5 TIU/ml Aprotinin, pH 7.4) and demembranated
with 0.5% Nonidet-P40 for 20 minutes. The axonemes were recovered by centrifugation
at 12000g for 10 minutes. The pellet was resuspended in ~300µl Buffer A. The protein
concentration was determined using the Bradford assay. The axoneme samples were
resuspended in Buffer A and fixed in sample buffer for SDS-PAGE at a concentration of
2 mg/ml.

2.5.3 Fractionation of Axonemal Proteins
To extract radial spoke complex, the isolated axonemes were resuspended in 0.6 M
potassium iodide (KI) / buffer A at 5 mg/ml for 30 minutes on ice. The mixture was
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centrifuged at 12,000 g for 10 minutes. The supernatant was dialyzed in Buffer A for 30
minutes on ice. The dialyzed liquid was centrifuged at 12,000 g for 10 minutes. The
supernatant was overlaid on an 11 ml 5-20% sucrose gradient. The gradient was
subjected to velocity sedimentation at 36,000 rpm (SW41 rotor, Beckman Coulter) for
10-16 hours at 4°C. 500 µl fractions were collected using the Econo peristaltic pump
(Bio-Rad). The fractions were fixed with 5X sample buffer for SDS-PAGE.

2.5.4 SDS-PAGE
Protein samples fixed with 5X sample buffer (10% SDS, 50% glycerol, 0.3 M Tris pH
6.8, 5% β-mercaptoethanol, 0.05% bromophenol blue) were boiled for 5 minutes at
100°C. The samples were loaded onto different percentage 8cm X 7cm minigels. The
electrophoresis was performed using 1X running buffer (27 mM Tris Base, 0.1% SDS
and 170 mM Glycine) as described by Laemmli (1970, 1973). A 5µl aliquot of molecular
weight marker (Fermentas) was used. Electrophoresis was carried out with Protean III
mini-gel apparatus (Bio-Rad) at 190 V for 0.5- 1 hour.

2.5.5 Native-PAGE
Protein samples were fixed with 5X sample buffer (50% glycerol, 0.3 M Tris pH 6.8, 5%
β-mercaptoethanol, 0.05% bromophenol blue). The samples were loaded onto different
percentage 8cm X 7cm native gels. Electrophoresis was performed using 1X running
buffer (27 mM Tris Base and 170 mM Glycine) (Ornstein, 1964; Davis, 1964). 1 mg/ml
BSA was fixed with 5X sample buffer for Native-PAGE and used as the marker.
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Electrophoresis was carried out with Protean III mini-gel apparatus (Bio-Rad) at 190 V
for 0.5- 1 hour.

2.5.6 Western Blot
After gel electrophoresis, the proteins fractionated in the gel were transferred onto a
nitrocellulose membrane. Depending on the size of the protein being transferred a 0.45
µm pore size membrane (> 40 KDa) or a 0.2 µm pore size membrane (< 40 KDa) (Pall
Corporation) was used. The transfer cassette which consisted of sponge, filter paper, gel
and membrane was placed into the gel box. The transfer was carried out using either Big
protein transfer buffer (> 40 KDa) (0.38 M glycine, 50 mM Tris base, 10% SDS, 20%
methanol) or small protein transfer buffer (< 40 KDa) (0.19 M glycine, 25 mM Tris base,
20% methanol). The transfer was carried out at 100 V for 50-60 minutes in a mini-gel
transfer apparatus (Bio-Rad). Following transfer, the membrane was stained with
Ponceau S (0.2% Ponceau S, 3% trichloroacetic acid, 3% sulfosalicylic acid) for about 2
minutes. The membrane was destained with deionized water. Subsequently the membrane
was blocked with 5% non-fat milk in 1X TBS, pH 7.4 (0.14 M NaCl, 2.6 mM KCl, 25
mM Trizma base) for 1 hour at room temperature. The blocked membrane was incubated
with primary antibody for 2 hours at room temperature. The blot was washed thrice, 5
minutes each, with 1 X TBS, followed by incubation with secondary antibody for 2 hours
at room temperature. The blot was washed again thrice with 1 X TBS. The protein bands
were then revealed by enhanced chemiluminescence (ECL) using a mixture of two
solutions: solution 1 (0.5 ml 1 M Trizma base pH 8.8, 50 µl 44 mg/ml luminol, 22 µl 15
mg/ml p-coumaric acid and 4.4 ml H2O) and solution 2 (0.5 ml 1 M Trizma base, pH 8.8,
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3 µl 30% H2O2 and 4.5 ml H2O). The blot was incubated with this mixture for 1 minute.
The blot was then exposed to autoradiography film (Denville Scientific) for different
periods of time and developed with an automatic film processor CP1000 (AGFA
healthcare).

2.5.7 Ni-NTA Affinity Purification
The vectors encoding GST-tagged RSP3 constructs and the His-tagged Dpy-30 constructs
were co-transformed into BL21 (DE3) cells. The transformants were inoculated into 5 ml
LB liquid medium supplemented with appropriate antibiotics. The liquid cultures were
incubated at 37°C in a shaker for ~2-3 hours (OD ~0.4-0.6). Following this the culture
was induced using 1mM IPTG, overnight at 16°C. Following induction, the cells were
spun down at 10,000 g for 1 minute. The cell pellet was resuspended in 750 µl Lysis
Buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) and sonicated using
a Branson digital sonifier. The sonicated cells were spun down at 12,000 g for 25 min at
4°C. 50 µl of the supernatant was saved as ‘pre’. The rest of the supernatant was applied
to Ni-NTA matric (100 µl) and incubated at room temperature for 1 hour. Following
incubation the mixture was spun down and 50 µl of the supernatant was saved as flow
through or ‘post’. The rest of the supernatant was discarded. The beads were washed
thrice using the wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH
8.0). Following the washes the bound protein was eluted using the elution buffer (50 mM
NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0). The samples were fixed in 5X
sample buffer and fractionated on SDS PAGE gels. The gels were blotted onto
nitrocellulose membranes and probed using the monoclonal GST antibody (Genscript).
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2.5.8 Overlay
Axonemal samples or bacterial samples were fractionated on SDS-PAGE gels. The gels
were transferred to nitrocellulose membrane (Ponceau staining is omitted). The blot was
blocked with 5% non-fat milk pH 7.4 in 1X TBS (0.14 M NaCl, 2.6 mM KCl, 25 mM
Tris base) for 30 minutes at room temperature. The blot was probed with 2 µg/ml purified
Dpy-30 protein for 2.5 hours at room temperature. The blot was washed once with 1 X
TBS. Subsequently the blot was probed with anti-Dpy30 antibody. The blot was washed
once with 1 X TBS and then incubated with horse radish peroxidase-conjugated antirabbit secondary antibody. The blot was washed once with 1 X TBS and developed using
enhanced chemiluminescence. The No ligand control was processed identically except
that the blot was not probed with Dpy-30 protein.

2.5.9 Chemical Blocker Screening with Native Gel Electrophoresis
The mixture of 2 µg of each protein in PBS was incubated at room temperature for 1.5
hours. Subsequently the reaction mixture was fixed with 5X native gel sample buffer.
The samples were fractionated on a native gel and visualized by Coomassie staining.
To identify compounds that inhibit the RSP3-Dpy-30 interaction, 2 µg purified
Dpy-30 was incubated with different compounds, at 25 µM, for 1 hour at room
temperature. Subsequently, purified GST-tagged RSP3 peptides were added to the
mixture to a final concentration of 1 µg/µl. After 1-hour incubation at room temperature,
the samples were fixed with sample buffer for Native PAGE and fractionated on a native
gel. The proteins were visualized by Coomassie stain.
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2.5.10 Chemical Blocker Screening with Ni-NTA Pull-Down
Aliquots of purified Dpy-30 protein were incubated with 50 µM compound for 1 hour at
room temperature. Following the incubation, the mixture was incubated with purified
GST-tagged RSP3 peptides at room temperature for 1 hour. A fraction of the mixture is
saved as ‘pre’ sample. To the remaining mixture, 20 µl Ni-NTA matrix were added and
the sample was incubated at room temperature for 1 hour. Following the incubation, the
reaction mixture was spun down and a fraction of the supernatant was saved as ‘post’
sample. 5X sample buffer for SDS-PAGE was added to the rest of the beads and spun
down. The supernatant along with the pre and post samples were fractionated on a SDSPAGE gel and visualized by Coomassie stain.

2.6 Sequence Analysis
Sequence alignments were generated using ClustalW2 program (http://www.ebi.ac.uk/
Tools/msa/clustalw2/). Coils program was used to define regions with high propensity to
form coiled coils (http://www.ch.embnet.org/software/COILS_form.html). PyMOL
(DeLano, 2002) was used to visualize the crystal structures of RIIa clan domains and also
align the structures. Secondary structure predictions were made using HNN (http://npsapbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_nn.html). Pfam database (http://pfam.
sanger.ac.uk/) was used to define proteins that contain RIIa clan domains.
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Chapter 3: RSP3 Forms the RS Scaffold with Two Distinct
Sites that Anchor RIIa Clan Domains
3.1 Introduction
Anchoring proteins are used by eukaryotic cells to localize molecules involved in signal
transduction, such as kinases, phosphatses, GTPases and phosphodiesterases (Scott and
Pawson, 2009; Klauck et al., 1996). This concept was founded on the discoveries of
anchoring proteins for cAMP-dependent protein kinase (PKA), the key effector
mechanism for cAMP (Theurkauf and Vallee, 1982). The PKA holoenzyme contains two
catalytic subunits and two regulatory subunits, RI or RII. Although PKA plays a central
role in the regulation of many cellular reactions, it has broad substrate specificity. It was
discovered that cells contain various A-Kinase Anchoring Proteins (AKAPs) to target this
promiscuous enzyme to specific sub-cellular locations (Welch et al., 2010).
Anchoring of PKA is mediated by a 14-18 a.a. amphipathic helix in AKAPs and
the RIIa domain in the regulatory subunit, RI or RII, in PKA (Carr et al., 1991). Many
AKAPs were identified solely based on the presence of an AH and the binding of RII in
vitro. However, the RIIa domain is not restricted to PKA alone. It has been found in
numerous proteins associated with various flanking sequences. Another RIIa like domain
known as the Dpy-30 domain is also found in equally numerous molecules with diverged
architectures. Together, all these proteins are classified into two subfamilies under the
RIIa clan in the Pfam database.
Interestingly, two proteins from each subfamily are subunits of the radial spoke
complex, a key regulatory element within the 9+2 axonemal machinery. RSP7 and
RSP11 contain a RIIa domains while RSP2 and RSP23 contain Dpy-30 domains (Yang et

53
al., 2006). These four proteins may contribute partly to the mechanism of this molecular
complex.
During flagellar beating, the RS couples the mobile CP with the dynein motors
that are attached to the outer doublets (Warner and Satir, 1974; Smith and Yang, 2004).
Precise coupling of these elements is critical for flagella to bend and to propagate the
bend. Consistently, RS appears rather rigid with slight elasticity under electron
microscopy. We reason that the rigidity for effective coupling of RS and the mobile CP
must be based on a single molecule extending throughout the spoke stalk as a core to
associate with other RS constituents that confer the effector mechanisms of the RS. The
first generation models in which the stalk is comprised of a string of RSPs (Yang et al.,
2006) are not likely to provide the necessary rigidity. Among the 23 RSPs, the best
candidate for this scaffold protein is RSP3.
First of all¸ a 300-a.a. region near the N-terminus is evolutionarily conserved, in
sequence as well as in length. The homology in length is consistent with the
extraordinarily conserved dimension of the RS and 9+2 axonemes from diverse
organisms (Mastronarde et al., 1992; Nicastro et al., 2006). Secondly, it was
demonstrated that RSP3 is essential for the assembly of the radial spoke (Huang et al.,
1981; Williams et al., 1989). Its N-terminus directly binds to the axonemes (Diener et al.,
1993). In addition, a downstream AH interacts with the RIIa domain (Gaillard et al.,
2001), presumably for binding the two RIIa RSPs. If RSP3 is the scaffold, sequence
toward the C-terminus will bind the Dpy-30 domain in RSP2 and RSP23. Thus we
hypothesize that the dimeric spoke AKAP, RSP3, forms the radial spoke scaffold and
contains two distinct sites that anchor the RIIa clan RSPs.
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This chapter describes in two sections the two main strategies that were taken to
test this hypothesis. The results from independent approaches consistently support the
hypothesis and demonstrate that RSP3 contains two distinct sites that associate with the
RIIa domain and the Dpy-30 domain respectively. Anchoring through these sites and the
RIIa clan domains localizes the rest of the molecular modules in these four RSPs to
precise locations for the assembly and modulation of the RS. The in vitro investigation
further defined the amphipathic binding site for the Dpy-30 domain.
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Section 1: In vivo approach
Sequence analyses were performed to identify the regions that may bind the Dpy-30
domain. Based on the prediction, truncation constructs of RSP3 genomic DNA were
engineered and Chlamydomonas mutants were generated. The mutant strains were
subjected to motility, biochemical and morphological analyses.

3.2 Results
3.2.1 Sequence Analysis of RSP3
We reason that the organization of the four RIIa clan members in the RS stalk must be
conducive to the predicted key property of the stalk-- rigidity—in order for the RS to
mechanically couple the mobile CP and outer doublets at a high frequency (Warner and
Satir, 1974). Higher rigidity may come from a RS with all four RIIa clan members
docking to a single or dimeric fibrous molecule extending throughout the complex than a
RS made from a continuous chain of individual RIIa clan members. The core molecule
that anchors the RIIa clan members should be long enough to span the distance from the
outer doublets to the CP. Furthermore, it should be conserved, as the dimension of
various axonemes is similar (Mastronarde et al., 1992; Nicastro et al., 2006). Sequence
analyses showed that among the 19 spoke components, the best candidate is RSP3, the
dimeric spoke AKAP which has the dimensions necessary to span the distance of the
spoke stalk (Discussed in Chapter 5) (Wirschell et al., 2008; Gaillard et al., 2001).
The AHR (a.a.# 161-178) (Gaillard et al., 2001) separates RSP3 into two
segments (Figure 3-1A): the N-terminal disordered region that binds axonemes (Diener et
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Figure 3-1. Sequence analyses and the model of RS.
(A) The secondary structure of RSP3 appears to be divided into two distinct areas by
the RIIa-binding site (red underline). The N-terminal 160 a.a. contains random coils
(purple) interspersed with short α-helices (blue) and β-strands (red), while the Cterminus is primarily composed of α-helices. Black bar, the RSP3 domain highly
conserved among RSP3 orthologues; Grey bar, the axoneme-binding region. (B)
RSP3 contains three areas with propensity to form coiled coils. The prediction was
made by Coils program using the window size of 28 a.a.. (C) A model depicting
RSP3 dimer (black and gray lines) as the core in the RS, with two sites for anchoring
RIIa (R) and Dpy-30 (D), dimerization and docking domains in two pairs of RSPs.
Each domain tethers distinct molecular moieties as effector mechanisms, like an
armadillo repeat protein (ARM), the calcium- binding EF-hands (Ca), coiled coils
(blue bars), nucleoside diphosphate kinase (NDK), RIIa binding amphipathic helix
(AHR).
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al., 1993; the grey bar) and a stack of LC8 dimers (Gupta et al., unpublished); and the Cterminus that is largely helical with a propensity to form three coiled coils (Figure 3-1B).
Coiled coils are known to promote protein-protein interactions. The N-terminal ~320-a.a.
region, upstream to Coil 2, is highly conserved and is recognized as a RSP3 domain by
the Pfam database (the black bar). Coil 2 is mildly conserved, whereas the C-terminus
including Coil 3 is unique to Chlamydomonas and is dispensable (Diener et al., 1993).
Thus we postulate that the dimer of the conserved region in RSP3 forms the core of the
RS, with binding sites for the axoneme as well as RIIa domain, Dpy-30 domain and
possibly the spokehead (Figure 3-1C).

3.2.2 RSP3 Truncation Mutagenesis Clarifies the Binding Region for the RIIa
Domain and its Tethered Moieties
Although point mutations in RSP3’s AHR abrogates the interaction of RSP3 with RII in
an overlay assay (Gaillard et al, 2001), the mutant strain expressing the same mutated
RSP3 polypeptide did not perturb the assembly of the RIIa-domain containing proteins
RSP7 and RSP11 (Gaillard et al., 2006). We predict that the inconsistency is because
RSP7 and RSP11 engage in multiple interactions with RSP3 and hence an alteration in
the AHR-RIIa interaction alone is insufficient to prevent their assembly. Therefore in
order to test whether the AH anchors the RIIa domain in RSP7 and RSP11, it is also
necessary to delete the area associated with their effector mechanisms. If the hypothesis
is correct, deletion of all involved sequences in RSP3 will result in an axoneme devoid of
these two molecules and possibly their associated molecules, such as RSP8 with ARM
repeats that are known to promote protein-protein interactions. Alternatively, retention of
the AHR alone may be sufficient to restore these two molecules. To alleviate folding
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issues due to inappropriate deletions, the designs of RSP3 deletion constructs were
guided by the predicted secondary structure.
Toward this end, we first created two complementary strains: the 1-178 strain that
terminates at the end of the AHR; and ∆1 strain lacking Coil 1 (a.a.# 171-244) and part of
the AHR. The third strain, ∆2, that lacks the small Coil 2 (#316-354), served as a control.
All truncated polypeptides retained the axonemal binding region at the first 80 a.a. and
thus could be assembled into the axoneme. To protect the truncated ends and to detect the
truncated polypeptide, the C-terminus of all RSP3 polypeptides was tagged with 3 HA
epitopes and 12 His residues. The tag also allowed quantitative comparison of the
truncated RSP3 variants in the axoneme.
All of the constructs for creating RSP3 mutant strains were modified from a
plasmid carrying the wild type (WT) RSP3 genomic DNA that was recovered from a
BAC clone. The truncated constructs were transformed individually into the RSP3 mutant
pf14 in which a premature stop codon results in diminished expression of the RSP3
polypeptide missing the axonemal binding site at the N-terminus (Williams, et al., 1989;
Diener et al., 1993). Since RSP3 mutants defective in the conserved region are paralyzed
like pf14 (Diener, et al., 1993), some of the truncated strains were expected to be
paralyzed as well. To aid the differentiation of paralyzed RSP3-positive clones from
paralyzed parental cells, an antibiotic resistance cassette was inserted into the plasmid for
single–plasmid transformation. The transformants were first selected for antibiotic
resistance. More than 100 antibiotic-resistant clones for each construct were screened
microscopically. All clones in both ∆1 and 1-178 groups were paralyzed. On the other
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Construct

# observed

# Motilea

# for flagella
prep.b

# HA +

∆1

160

0/160

23

5/23

∆2

118

50/118

16

7/16

1-178

40

0/40

10

2/10

a

The suspension contains swimmers.
The quantity from each quick flagellar preparation varied. The yield of some clones
was low because of fewer flagellated cells or had difficulties in shedding flagella.

b

Table 3-1. Screening of RSP3 truncation mutants.
Single colonies of antibiotic-resistant transformants were randomly picked and restreaked on agar plates. A fraction of each colony was resuspended for light
microscopy. A crude flagella preparation was made from a plate of clones randomly
selected from the group of ∆1 and 1-178 that were 100% paralyzed; or from the
clones with swimmers from the group of ∆2. The samples were then assessed by HA
western blots. #, colony numbers.
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hand, among the 118 ∆2 clones screened, 50 clones contained motile cells (Table 3-1),
indicating substantial amount of ∆2-RSP3 polypeptides were restored to the axoneme of
40% of the antibiotic-resistant strains. In the case of the paralyzed clones, the plasmid
may not have inserted into the genome properly to express the truncated RSP3 in
sufficient quantity. These data suggest that ∆2-RSP3 can restore the motility to pf14
flagella, whereas ∆1 RSP3 cannot rescue the motility, even if the truncated polypeptides
are restored to the axonemes.
A quick preliminary screen was conducted to identify clones with truncated RSP3
in their flagella. 10 clones were randomly selected from the paralyzed ∆1 and 1-178
groups; and from the motile clones in the ∆2 group. A small crude flagella preparation
was made from a plate of each clone for HA western analysis (not shown). The clones
with HA-positive flagella were cultured in liquid media for axoneme preparations.
Western blots of near equal loads of axonemes were probed for representative RSPs
(Figure 3-2). The clone expressing wild type (WT) RSP3-HAHis served as the positive
control. The negative control was the spoke-less pf14. The representative HA western
blots showed that in all strains except pf14, the amount of RSP3 variants in axonemes
were similar. For the ∆1 strain that was missing Coil 1 (a.a.# 171-244) that includes part
of the AHR (a.a.# 161-178) in RSP3, both the RIIa-containing RSP7 and RSP11, as well
as RSP8, the ARM repeat protein, were absent (Figure 3-2), while all the proteins in the
spoke head and neck region were present at normal levels. The assembly of the Dpy-30containing RSPs at the neck when the RIIa-containing RSPs located between the neck
and the base are absent indicates that the RS is not comprised of a string of individual
RIIa clan RSPs. Conversely the 1-178 axonemes, in which the entire AHR
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Figure 3-2. Truncation around the Coil 1 region results in deficiencies in RIIadomain-dependent assembly.
Western blots of axonemes (left panel) from WT and the RSP3 strains defective in
the region around coiled coils (right panel) were probed for relevant RSPs as
indicated. The RIIa proteins (RSP7 and 11) and the ARM (RSP8) were missing in
the ∆1 strain in which half of the RIIa-binding AH is truncated. These proteins
appeared normal in ∆2 axoneme. The 1-178 axonemes that contains RSP3 sequence
up to the AH lacked all the proteins in the spokehead and spokeneck but contained
the RIIa proteins (RSP7 and RSP11). Note RSP8 was less abundant. The spoke-less
pf14 was the negative control. IC140, an inner dynein arm subunit, indicated the
protein loading.
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(a.a.# 161-178) was retained, both RSP7 and RSP11 were present, but the spoke head
proteins (RSP1, RSP4, RSP6) and neck proteins (RSP2, RSP23 and RSP16) were absent
(Figure 3-2). Therefore, AHR is sufficient to anchor the two non-PKA RIIa proteins. Note
RSP8 was less abundant in 1-178 axonemes than in the WT, like the axoneme of the
RSP11 mutant pf25 that lack RSP11 (Yang et al., 2006). The RSP8 deficiency in the
axoneme defective in Coil 1 (1-178 or ∆1) or lacking RSP11 supports the prediction that
RSP11 and RSP8 form a tri-molecular sub-complex with RSP3 Coil 1 region (Figure 31C). Furthermore, the fact that the C-terminus up to Coil 3 is dispensable (Diener et al.,
1993); and Dpy-30-domain-containing RSP2 and RSP23 are absent in 1-178 strain but
normal in ∆1 and ∆2 strains suggest that the Dpy-30-domain-binding site is located
between Coil 1 and Coil 2.

3.2.3 A Downstream Helical Region Associates with Dpy-30 Domain Containing
Proteins
To define the Dpy-30-domain-binding region in RSP3, we took the same strategy to
generate three more strains in which RSP3 terminated at different residues between Coil
1 and Coil 2, i.e. a.a.# 244, 269, 316 respectively. As expected, all clones in the 1-244
and 1-269 groups were paralyzed (Table 3-2). As the ∆2 group, approximately 40% of
the clones in the 1-316 group contained swimmers. This further confirms that the less
conserved Coil 2 region is dispensable. Preliminary western blots of flagella from
selected clones identified the RSP3 (HA)-positive clones. The axonemes from these
clones were subjected to detailed analyses.
Western blots showed that the axonemes from the paralyzed 1-244 and 1-269
strains, like the 1-178 strain, were deficient in the neck proteins (RSP2, RSP23 and
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Construct

# observed

# Motilea

# for flagella
prep.b

# HA +

1-244

50

0/50

10

3/10

1-269

92

0/92

10

2/10

1-316

114

47/114

10

7/10

a

The suspension contains swimmers.
The quantity from each quick flagellar preparation varied. The yield of some
clones was low because of fewer flagellated cells or had difficulties in shedding
flagella.
b

Table 3-2. Screening of RSP3 truncation mutants.
Single colonies of antibiotic-resistant transformants were randomly picked
and re-streaked on agar plates. A fraction of each colony was resuspended for
light microscopy. A crude flagella preparation was made from a plate of
clones randomly selected from the group of 1-244 and 1-269 that were 100%
paralyzed; or from the clones with swimmers from 1-316 group. The samples
were then assessed by HA western blots. #, colony numbers.
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Figure 3-3. Truncation between the first two coils results in deficiencies in Dpy-30domain-dependent assembly.
Western blots of axonemes (left panel) extracted from WT and three mutants with
different truncations distal to Coil 1 (right panel) were probed for relevant RSPs as
indicated. 1-244 strain and 1-269 strain were deficient in the spokehead proteins and the
spokeneck proteins including RSP16 and the two Dpy-30-domain- containing RSP2 and
RSP23. These proteins were present in 1-316 strain but the spokehead proteins were less
abundant than that in the WT control. The spoke-less pf14 was the negative control.
IC140, an inner dynein arm subunit, indicated the protein loading.
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RSP16) and the head proteins (RSP1, RSP4 and RSP6) (Figure 3-3). This suggests that
the region involved in the head-neck assembly and anchoring the Dpy-30 domain is
within a.a.# 269-316 in RSP3. For the 1-244 and 1-269 strains that retain both AHR and
Coil 1, the axoneme had normal amounts of RIIa-domain-containing RSP7 and RSP11 as
well as the ARM repeat protein RSP8. This result further supports the prediction that the
mutually interacting RSP11 and RSP8 bind to AHR and Coil 1.
In 1-316 axonemes in which RSP3 lacks both Coil 2 and Coil 3, the Dpy-30domain- containing RSP2 and RSP23, and RSP16 were present in normal levels as
expected (Figure 3-3). The head proteins (RSP1, RSP4 and RSP6) were also present, yet
their amounts were drastically reduced compared to WT axonemes. These head proteins
were also less abundant in the RSP2 mutant pf24 (Huang et al., 1981; Patel-King et al.,
2004; Yang et al., 2006). The same spokehead deficiencies due to the defect either in
RSP2 or in the C-terminus of RSP3 suggests that RSP2 and RSP3 Coil 2 region are both
involved in the assembly of the spokehead. Furthermore, the 47-a.a. RSP3269-316 may
anchor the Dpy-30 domain directly. The precise binding site was determined by in vitro
experiments described later.

3.2.4 Truncations in RSP3 Lead to Smaller Spoke Particles
To assess the RSs with truncated RSP3 independently, we took two more approaches.
Firstly, RSs were extracted from axonemes with KI buffer and the dialyzed extract was
fractionated by sucrose gradient velocity sedimentation. The fractions of the gradient
were then assessed by western blots (Figure 3-4). The RS complex from the WT control
sample sedimented as an intact particle with a single 20S peak (Yang et al., 2001). For all
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Figure 3-4. Radial spokes extracted from mutants largely sedimented as smaller
particles.
The KI axonemal extracts from the indicated strains were sedimented through a 525% sucrose density gradient and the fractions were assessed by western blots probed
for relevant RSPs. The major peaks were indicated by arrows. The extracted RSPs
from all truncation mutants sedimented together as intact particles smaller than WT
RSs. A second RSP3 peak (asterisk) was present in the gradients from ∆1 and 1-178
strains that lacked Coil 1.
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the mutants, RSs with truncated RSP3 sedimented as smaller particles, similar to or
smaller than RS stalk particles from the mutants lacking the head proteins (Yang et al.,
2001). While the gradients of 1-244, 1-269 and 1-316 strains contain a single RSP3 peak,
the gradients of the ∆1 and 1-178 strains that lack Coil 1 contained another minor peak,
suggesting that Coil 1 is critical to the unusual stability of the RS complex, possibly for
the formation of a dimeric coiled coil.

3.2.5 Electron Microscopy Reveals Distinct Dwarf RSs in RSP3 Mutant Axonemes
To verify the hypothesis independently, the morphology of the RS with truncated RSP3
was assessed by electron microscopy (EM). Due to the resolution of EM and the similar
sizes of the RS particles in the mutants, we only compared the axonemes of WT, ∆1 and
1-178 strains (Figure 3-5A). If the proposed model is correct, the two RSP3 truncation
mutants would have shorter RSs with and without the spokehead respectively (Figure 35B).
The EM images of axoneme cross sections revealed two main defects, a lateral
shift of the CP, a signature of prominent RS defects (Witman et al., 1978); and stubby
RSs (Figure 3-5A and Table 3-3). Importantly, some RS stubs in ∆1 axonemes but not 1178 axonemes exhibited an enlarged head (Insets), consistent with the presence of head
proteins only in the ∆1 axonemes (Figure 3-2) and the proposed model (Figure 3-5B).
The RSs, measured to outer doublets, are the longest in the WT and the shortest in 1-178
(Figure 3-5C). About 92% of ∆1 images and about 69% of 1-178 images had deviated CP
(Table 3-3). The more prominent shift of the CP in ∆1 despite longer RS may be due to
their spokeheads that could adhere and actively detract the CP off the center.
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A

B

C

Figure 3- 5. Distinct stubby spoke in the axonemes from the ∆1 and 1-178
mutants.
(A) The representative images of cross-sectioned axonemes revealed by
transmission electron microscopy. Full length RSs on each outer doublet tug the
central pair apparatus to the center of the WT axonemes. The RSs in the axonemes
of ∆1 and 1-178 strains were shorter, resulting in the lateral shift of the central pair
apparatus in some axonemes. However, only the dwarf RSs in ∆1 axonemes
contain slightly enlarged spokehead. The bottom panel gives an enlarged view of
the axoneme cross sections. The arrows highlight the defective radial spokes. (B)
Schematic pictures depicting the RSs in each strain. (C) The lengths of RSs in
cross sectioned axonemes.
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Strain

% of axonemes
with deviated CP

# of Axonemes
measureda

% deviation of the
CP

WT

3.7% (n=27)

-

-

14

16.6%

3

15%

2

20%

9

16.6%

5

20%

∆1

1-178

92% (n=38)

69% (n=39)

n, the total number of cross-sectioned axoneme images that were visually
inspected.
a
The number of axonemes with a deviation that was large enough to be
measured
Table 3-3. The incidence of lateral-shifted central pair (CP) apparatus in
axonemes and the extent of deviation.
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The combined results from motility, biochemical and morphological analyses
support the proposed model (Figure 3-1C) -- RSP3 dimer extends throughout the
spokestalk with two discrete regions for anchoring the two types of D/D domains in four
RSPs. A region near Coil 2 anchors the Dpy-30 domain present in RSP2 and RSP23. The
helices downstream to the binding region in both RSP2 and RSP3 may form coiled coils
with each other and with the head components. As for RSP23, the Dpy-30 domain could
tether the associated NDK to the RS complex. Finally, the coiled coils adjacent to the
docking and anchoring region in RSP2 and RSP3 associate with the spokehead (Yang et
al., 2008). Through these multiple interactions, the head, neck and stalk are linked
together.
For the two RIIa-containing proteins, RSP11’s RIIa domain docks onto the AHR
in RSP3 while its short flanking sequence tethers the ARM repeat protein (RSP8) to
interact with the Coil 1 region in RSP3 directly or indirectly. We speculate that this may
enhance the rigidity of the dimeric RSP3 core, since the mutants defective in RSP11 can
swim but become paralyzed in the exhausted media (Yang and Yang, 2005). By the same
token, RSP7’s RIIa domain docks to AHR in the other RSP3 monomer. Yet contrary to
the constitutive function of RSP11, RSP7’s EF-hands could allosterically modulate the
stalk when calcium increases, analogous to the cAMP-induced release of the PKA
catalytic subunit. These various effector mechanisms of the four RSPs are all docked
through the D/D domains to the two regions in RSP3.
Taken together, with all these molecular interactions throughout the RS, including
the association with the axonemal outer doublets (Diener et al., 1993), the dimeric RSP3
clearly is a bona fide core scaffold of the entire RS complex. The effectors anchored
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through AH-D/D domains facilitate the assembly of the rest of RSPs and modulate the
scaffold itself in calcium-dependent and independent manner. Such a model depicts the
RS with sufficient rigidity to mechanically couple the CP and outer doublets during
oscillatory beating and can be modulated when calcium induces changes in oscillatory
beating.
There are several alternative models. For instance, each 96-nm repeat contains
two RSs and each of the two RSPs with the same D/D domain may reside in only one RS.
However, this model is inconsistent with the co-assembly and direct interaction of the
Dpy-30-domain containing RSPs. RSP23 is diminished when RSP2 is diminished in the
axoneme of RSP2 mutant pf24. Furthermore, these two molecules and their human
counter parts, directly interact with each other in the pull-down experiments and in the
yeast two-hybrid system (Kohno et al., 2011; Rual et al., 2005). The second possibility is
that the RIIa clan domain containing proteins can form heterodimers. However, we have
not succeeded in coercing the formation of hetero-dimers. Recently it was shown that
RSPs form smaller sub-particles in the cell body of the RSP3 mutant pf14 (Diener et al.,
2011). Perhaps, homodimers of RSP2 and RSP23 form a hetero-tetramer prior to docking
to the RSP3 dimer. Preformed sub-complexes may ensure each RS contains both RIIaRSPs and both Dpy-30-RSPs.
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Section 2: In vitro approach
Although the in vivo approach provides results with in vivo relevance, it is not possible to
demonstrate unequivocally the direct interaction because of the inherent assembly
mechanism of axonemal complexes in the cell body. For example, the five spokehead
components pre-assembled as a unit (Diener et al., 2011). All five proteins are absent
even when one protein is defective (Huang et al., 1981). Thus, to test the direct
interaction between RSP3 and the RIIa clan domains we took an in vitro approach. In
addition, it is possible to express small fragments of interest in vitro while in the in vivo
setting deleting the N terminus of RSP3 which is essential for the assembly of the RS is
not feasible (Diener et al., 1993).
Short fragments of RSP3 were synthesized as a fusion protein with a glutathione
S-transferase (GST) tag at the N-terminus. The GST tag was chosen for several reasons;
to serve as a carrier that would protect the short fragment from degradation, the highly
soluble GST tag would aid in the efficient expression of the peptides in the bacterial
system. Furthermore, the tag would serve as a marker for the detection of the peptides.
Lastly, its affinity to glutathione can be exploited to purify the peptides using glutathione
agarose beads.
Conversely, the polypeptides with the RIIa domain or the Dpy-30 domain were
fused to a 6 His sequence for similar reasons. The affinity of the His tag for Ni2+ ion
enables the pull-down and affinity chromatography of the fusion proteins using Ni-NTA
matrix. To test the interaction between the peptides of interest and the RIIa or Dpy-30
domain, a vector that encodes the GST tagged truncated RSP3 constructs was cotransformed into bacteria along with a vector that encodes the His tagged RIIa or Dpy-30
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domain. This system allowed us to test with either the glutathione affinity matrix or the
nickel affinity matrix. If the two fusion proteins interact, then both molecules should be
pulled down using either glutathione or nickel affinity matrix. In this project, Ni-NTA
affinity matrix was primarily used.

3.3 Results
3.3.1 RSP3 Directly Interacts with RIIa domain of RSP7 and Dpy-30 Domain
Previous studies have shown that N-terminus of RSP3 (161-178 a.a) interacts with RII
(Gaillard et al., 2001), while RSP3 can be co-purified with RSP11 (Yang et al., 2006).
However, perturbing this RIIa binding site did not abolish the assembly of RIIa-domain
containing RSP7 or RSP11 (Gaillard et al, 2006). The results from the in vivo approach
have verified that the AH sequence is used to anchor the RIIa domain in these two nonPKA proteins. Hence we used the RIIa domain of RSP7 as an example to demonstrate the
direct interaction between the AH and the RIIa-domain from these non-PKA proteins.
For the Dpy-30 domain, the in vivo studies have mapped its binding sequence to a helical
region (269-316 a.a) downstream to the RIIa-binding AH.
Three short peptides within these two regions in RSP3 were generated, RSP396180,

RSP3245-316 and RSP3269-316. The coding sequence for these fragments were PCR-

amplified and cloned into pGEX-2T vector, resulting in the expression of fusion proteins
with a GST tag at the N terminus. The RIIa domain of RSP7 as well as Dpy-30 was
cloned into pET-28a vector, resulting in the expression of a N-terminally His-tagged
polypeptide in the case of Dpy-30 and C-terminally tagged polypeptide in the case of
RIIa.
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The constructs for GST-tagged RSP396-180, which contained the RIIa-binding AH
at a.a.#161-178 a.a, and for the His-tagged RIIa were co-transformed into BL21(DE3)
cells. The transformants were screened by double selection using culture plates that
contained both carbenicillin (pGEX-2T) and kanamycin (pET-28a). The surviving clones
were cultured and the proteins were induced by IPTG. As predicted, GST-tagged RSP396180 was

co-purified with the His-tagged RIIa domain by Ni-NTA (Figure 3-6A). This

result served as a positive control and confirmed the interaction between the AH (161178 a.a) and the RIIa domain.
The Dpy-30 domain containing RSPs, RSP2 and RSP23, were not amenable for this
study due to their tendency to precipitate. Hence human Dpy-30 protein was coexpressed with RSP3 polypeptides. The human Dpy-30 protein was cloned into pET-28a
vector which resulted in a His-tagged polypeptide. GST-tagged RSP3245-316 and RSP3269316 were

co-transformed into BL21(DE3) cells along with His-tagged human Dpy-30

protein. The transformants were induced with IPTG overnight at 16°C. The His-tagged
human Dpy-30 proteins were pulled down using nickel beads. The samples which
included ‘pre’, ‘post’ and the ‘elute’ were fractionated on SDS PAGE gels and visualized
by Coomassie staining. Both RSP3245-316 and RSP3269-316 were pulled down along with
human Dpy-30 protein (Figure 3-6 B and C). This result confirms the direct interaction
between the candidate region (269-316 a.a) and human Dpy-30 protein. As a negative
control, pGEX-4T vector with no insert was also co-expressed with human Dpy-30
protein to demonstrate that GST tag on its own does not interact with human Dpy-30
protein (Figure 3-6 D).
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A

B

C

D

Figure 3-6. Two regions in RSP3 bind to the RIIa and the Dpy-30 domain
in vitro.
(A) His-tagged RIIa from RSP7 (asterisk) or His-tagged Dpy-30 protein
(arrowhead) were co-expressed with a RSP3 peptide tagged to GST (dot). The
Ni-NTA pull-down was analyzed by Coomassie stained protein gel. (A) The
positive control, the co-purification of the RIIa domain and the 96-180 fragment
containing the RIIa-binding AH (Gaillard, 2001). (B) and (C) The copurification of Dpy-30 protein and GST tagged RSP3 fragments (dot). (D) The
negative control, showing that GST alone does not interact with Dpy-30 protein.
Pre, the bacterial extract; Post, the flow through from Ni-NTA matrix; and E,
the eluate.
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These co-expression studies provided evidence for the direct interaction of the
AH with the RIIa domain and RSP3269-316 with the Dpy-30 protein.

3.3.2 Defining the Dpy-30 Domain Binding Site
In order to compare the binding sites of the RIIa clan domains we defined the exact Dpy30 binding site within 269-316 a.a. Smaller constructs were engineered that expressed
different regions within 269-316 a.a. All the RSP3 polypeptides were tagged with GST at
the N terminus and cloned into the pET-Duet vector. The GST tagged RSP3 polypeptides
were co-expressed in BL21(DE3) cells along with His-tagged human Dpy-30 protein.
The human Dpy-30 protein was subjected to affinity purification and pulled down using
Ni2+ beads. The samples which included the ‘pre’, ‘post’ and the ‘elute’ were fractionated
on SDS PAGE gels and RSP3 polypeptides were detected using the α-GST antibody.
RSP3280-316 and RSP3280-308 were effectively pulled down by human Dpy-30 protein
(Figure 3-7). RSP3280-306 however was not able to pull-down human Dpy-30 protein
(Figure 3-7). Thus the Dpy-30 protein binding site was narrowed to the 28 a.a. region
between #280-308.
AKAPs interact with the RIIa domain through a 14-18 residue amphipathic helix
(Carr et al., 1991). Hence the 18 residue RIIa domain binding site in RSP3 (161-178 a.a)
forms an amphipathic helix. Previous studies have shown that when the amphipathic
helix is disrupted by introducing point mutations, the binding with the RIIa domain is
abrogated (Carr et al., 1992; Gaillard et al., 2001). We speculate that the other member of
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Figure 3-7. The Dpy-30 protein binds to a.a.# 280-308 in RSP3.
His-tagged full-length Dpy-30 protein was co-expressed with GST-tagged
RSP3 peptides and then subjected to Ni-NTA pull-down. The protein
samples fractionated by SDS-PAGE were probed for GST. The smallest
region that bound the Dpy-30 protein was a.a. # 280-308. The interaction was
perturbed by V300P mutation. Pre, the bacterial extract; Post, the flow through
from Ni-NTA matrix; and E, the eluate.
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the RIIa clan, Dpy-30 domain would also bind to similar amphipathic helices. Thus
creating point mutations within the Dpy-30 binding site that disrupt the helicity of the
region should abrogate its binding with the Dpy-30 domain. To test this we generated
RSP3280-316 polypeptide that contained a point mutation which replaced valine at 300 with
a proline. The RSP3 polypeptide containing the mutation was cloned into the pET-Duet
vector. The vector containing mutated RSP3 protein was transformed into BL21-DE3
cells along with His tagged human Dpy-30 protein. The transformants were expressed
and subjected to affinity purification (as described before). The mutated RSP3
polypeptide was not able to pull-down human Dpy-30 protein (Figure 3-7). This suggests
that the binding principles of both the RIIa clan domains are very similar.

3.3.3. Dpy-30 Protein Interacts with RSP3 through the Dpy-30 Domain
The co-expression studies were carried out with full length human Dpy-30 protein.
However, Dpy-30 protein is 99 amino acids in length. In addition to the 40 a.a. Dpy-30
domain in its C terminus, it has 59 additional residues. To clarify that the interaction
between RSP3 polypeptides and the human Dpy-30 protein occurred through the 40 a.a.
Dpy-30 domain, we engineered a construct that expresses the Dpy-30 domain alone. This
construct (Dpy-3045-99) was cloned into the pET-28a vector resulting in a His tagged
protein. Dpy-3045-99 was co-transformed into BL21(DE3) cells along with the GSTtagged RSP3 constructs. The transformants were subjected to affinity purification using
Ni-NTA matrix. The ‘pre’, ’post’ and ‘elute; samples were fractionated on SDS PAGE
gels and detected by probing with α-GST antibody. As anticipated the results obtained
using full length human Dpy-30 protein were replicated using Dpy-3045-99 (Figure 3-8).
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Figure 3-8. The Dpy-30 domain binds to a.a.# 280-308 in RSP3.
His-tagged Dpy-30 domain was co-expressed with GST-tagged RSP3 peptides
and then subjected to Ni-NTA pull-down. The protein samples fractionated by
SDS-PAGE were probed for GST. The smallest region that bound the Dpy-30
domain is a.a. # 280-308. The interaction was perturbed by V300P mutation. Pre,
the bacterial extract; Post, the flow through from Ni-NTA matrix; and E, the
eluate.
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This suggests that the interaction between RSP3 polypeptides and the human Dpy-30
protein occurs through the Dpy-30 domain. Thus the co-expression studies allowed us to
narrow down the Dpy-30 binding site to 28 a.a between residues 280 and 308 and also
demonstrate that the binding principle of both the RIIa clan domains is highly similar.

3.3.4 Construction of a Dpy-30/RSP2 Hybrid Molecule
The low expression and precipitation propensity of RSP2 and RSP23 precludes their
usage in co-purification experiments. We speculate that these problems can be overcome
by creating a hybrid molecule, using the N-terminal half of the Dpy-30 protein to carry
RSP2’s Dpy-30 domain. The hybrid molecule might remain soluble and could be used to
test if the RSP2’s Dpy-30 domain can bind to the partner sequence in RSP3.
Swapping the Dpy-30 domain in these two molecules is not straightforward, since
the domain is at opposite positions in these two molecules. For RSP2, it is located in the
N-terminus. For Dpy-30 protein, it is located at the C-terminus. The N-terminal region
(1-45 a.a) of Dpy-30 protein and the Dpy-30 domain of RSP2 were PCR-amplified and
cloned into pET-28a vector. The final construct would express a His-tagged hybrid
polypeptide including the first 45 a.a. residues from the N-terminus of Dpy-30 protein
preceding RSP2’s Dpy-30 domain. To test its interaction with the RSP3 sequence, the
hybrid construct was subjected to co-expression and co-purification with the GSTRSP3280-308 construct.
While the hybrid did bind RSP3280-308, its binding efficiency was poorer than that
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Figure 3-9. The Dpy-30 binding domain (RSP3280-308) binds to the hybrid
molecule albeit with low affinity.
His-tagged hybrid construct which contains the Dpy-30 domain of RSP2 was
co-expressed with GST tagged RSP3 polypeptides and subjected to Ni-NTA
pull-down. The samples were fractionated on SDS –PAGE gels and probed for
GST. The Dpy-30 binding region was pulled down by the hybrid construct
while the construct harboring the point mutation was not co-purified. ‘Pre’ the
bacterial extract, ‘Post’ the flowthrough from Ni-NTA matrix, ‘E’ the eluate.
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of Dpy-30 protein (Figure 3-9). However, the binding was even poorer when GSTRSP3280-308 was co-expressed with the V300P mutation construct (Figure 3-9). This
suggests that RSP2’s Dpy-30 domain binds RSP3280-308, albeit with low affinity.
Although, the hybrid protein allowed us to circumvent the solubility and
expression problems of the RSP2 polypeptide, its affinity for RSP3280-308 was not as high
as that of Dpy-30 protein. This lesser efficiency could be attributed to the tethered
sequence in RSP2. The last helix in RSP2’s Dpy-30 domain forms a continuous helix of
coiled coil propensity with flanking sequence. In engineering the hybrid construct this
continuous helix was perturbed and may account for the low binding affinity of the
hybrid construct. Additionally, recent studies on RIIa domains have shown that the
sequences outside the domain do participate and contribute to the specificity and affinity
of binding (Christian et al., 2011). In the same vein, utilizing the Dpy-30 domain of RSP2
without the downstream flanking sequence could severely compromise the binding
affinity.

3.3.5 Comparing the RIIa Clan Domains
Sequence alignment of RIIa and Dpy-30 domains from different proteins showed that
there is considerable similarity between these domains (Figure 3-10). Both of the
domains adopt a helix-loop-helix morphology. The RIIa domain structure is described as
a X-shaped four helix bundle. It consists of two helix-loop-helix monomers that dimerize
to form a hydrophobic groove to which the amphipathic helix of AKAP binds (Figure 311 A) (Newlon et al., 2001; Gold et al., 2006). The N terminus of the RIIa domain of RIIPKA is considered to be disordered and has been shown to form key contacts with
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Dpy-30
KAD7_HUMAN/679-720
NDK5_HUMAN/156-197
DPY-30_HUMAN/52-93
DPY30_CAEEL/69-110
RSP2_CHLRE/8-49
RSP23_CHLRE/152-197

Helix I

Loop

Helix II

PLRNYLMTYVMPTLIQGLNECCNVRPE----DPVDFLAEYLFKNNP--AAKDYLNLHIMPTLLEGLTELCKQKPA----DPLIWLADWLLKNNP--PTRAYLDQTVVPILLQGLAVLAKERPP----NPIEFLASYLLKNKA--PTRQYLDSTVVPILLQGLGALAKDRPE----NPIEFLANFLLREKD--HDTAYLKETVGEALARGCAAAISAQPN----DPVEYLGLWLLKYVK--AAAEYITKRIQPALAKALAALAREKPSADKFEAITFVAGYLLQNNP---

RIIa (RI)
Q17QF5_BOVINE/25-62
KAP1_RAT/25-62
A6YCE2_HUMAN/25-60
Q96P62_HUMAN/25-59
A2AI69_MOUSE/25-62

-------RGIQQVLKDCIVQLCLAKPE----RPMRFLREHFERLEKEEN
-------HGIQQVLKECIVHLCVAKPD----RPLRFLREHFEKLEKEEN
-------HNIQALLKDSIVQLCTARPE----RPMAFLREYFERLEKP--------HNIQALLKDSIVQLCTARPE----RPMAFLREYFERLEK---------HNIQALLKDSIVQLCTTRPE----RPMAFLREYFERLEKEEA

RIIa (RII)
KAP2_HUMAN/8-45
KAP2_MOUSE/8-44
Q6NW93_ZEFSH/7-44
RSP11_CHLRE/16-50
RSP7_CHLRE/13-50
CABYR_HUMAN/12-49

-------PGLTELLQGYTVEVLRQQPP----DLVEFAVEYFTRLREARA
-------PGLTELLQGYTVEVG-QQPP----DLVDFAVEYFTRLREARR
-------AGLPELLRGFTLEVLRRQPA----DLLEFSVRYFTGLRDTRS
------PHNLADILKAYTKEVIRRQPT----DLIAFSAKYFTNLAN---------EGFPQLLKAFTREILRNQPD----NIYEFGAKYFEDLIEENK
-------YGLKTLLEGISRAVLKTNPS----NINQFAAAYFQELTMYRG

Figure 3-10. Sequence Alignment of the RIIa clan domains.
Sequence alignment displays the similarities between the RIIa clan domains from
various molecules. The regions forming helix-loop-helix structures are underlined.
The conserved hydrophobic residues and prolines are highlighted. Accession
numbers for Dpy-30 domain proteins: KAD7 (Q96M32), NDK5 (P56597), DPY-30
Human (NP_115963), DPY-30 C.e. (NP_506058), RSP2 (XP_001702718.1),
RSP23 (XP_001698136). Accession numbers for RIIa (RI) domains: KAP1
(P81377), A6YCE2, Q96P62, A2AI69. Accession numbers for RIIa (RII) domains:
KAP2 Human (P13861), KAP2 Mouse (P12367), RSP11 (ABC02022), RSP7
(ABC02026), CABYR (NP_036321).

84

A

B

C

D

Figure 3-11. Comparison of crystallographic structures of the Dpy-30 domain
and the RIIa domains from PKA.
(A) The domain from RII (PDB ID: 2HWN). (B) The domain from human Dpy-30
protein (PDB ID: 3G36). (C) and (D) The alignment of the Dpy-30 domain (blue)
with the RIIa domain (pink) from RII and RI (PDB ID: 3IM4) respectively.
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residues in AKAP (Kinderman et al, 2006). The RIIa domain of RI-PKA also adopts a Xshaped four helix bundle like structure. The hydrophobic groove that binds AKAP is
created by the dimerization of two helix loop helix dimers (Banky et al., 2003; Sarma et
al., 2010). The N terminus of the RIIa domain of RI-PKA differs from the RIIa domain of
RII-PKA. It consists of key di-sulphide bridges that are essential for the dimerization of
the domain. The RIIa domain of RI-PKA also contains an extended N terminus that folds
inward resulting in a binding pocket that is much deeper than the RIIa domain of RIIPKA. It is speculated that the binding pocket of RI-PKA can accommodate bulky and
aromatic residues unlike the flat hydrophobic groove of RII-PKA (Sarma et al., 2010).
The Dpy-30 domain structure is also described as a X-shaped four helix bundle. It
also consists of two helix-loop-helix monomers that dimerize to form a groove or binding
pocket (Wang et al., 2009) (Figure 3-11 B). This groove is primarily hydrophobic in
nature. The structure of Dpy-30 in complex with its binding partner has not been solved;
hence it is not known how the interacting protein occupies this hydrophobic groove. But
drawing on analogies to the RIIa domain structure, it is reasonable to speculate that the
interaction between Dpy-30 domain and its binding partner would be very similar to the
interaction between RIIa domain and AKAP.
To compare the Dpy-30 domain and the RIIa domain of RI and RII-PKA, the
structures were aligned using PyMOL (Figure 3-11 C and D). The alignment showed that
although the core structure of the RIIa clan domains is similar, the Dpy-30 domain is
more similar to the RIIa domain of RI-PKA (Figure 3-11 D). Like the RIIa domain of RIPKA, the N terminal region of Dpy-30 domain also contains an extended helix that fold
inwards resulting in a deeper binding pocket. The binding pocket of the Dpy-30 domain
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has been described as less flat and less hydrophobic compared to the RIIa domain of RIIPKA (Wang et al., 2009). These differences may be key to afford specificity to these
domains. Thus the RIIa clan domains exhibit several similarities and a few key
differences.

3.3.6 Comparing the RIIa Clan Domain Binding Sites
The similarities between the RIIa clan domains led us to compare the RIIa clan domain
binding sites from various proteins in various organisms. The binding sites of RIIa clan
domains were analyzed using helical wheel programs. The binding sites formed
amphipathic helices with a distinctly hydrophobic face and a hydrophilic face. The
amphipathic nature of RIIa domain binding sites is a well-documented finding. But the
finding that this feature is also shared by Dpy-30 domain binding sites is novel (Figure 312 B). This finding reinforces the similarity in the binding principle of these domains.
Sequence comparison of RIIa and Dpy-30 domain binding sites did not reveal
considerable identity. But when examined closer, it revealed conservation in the pattern
of the sequences. Analyzing the RIIa and Dpy-30 binding sites from different proteins in
different organisms we found that these binding sites contained hydrophobic residues that
repeat in pairs interspersed by non-hydrophobic residues (Figure 3-12 A). These repeats
were designated as ‘hydrophobic dyads’. Some binding sites contained four such pairs
while some contained three pairs. This difference in number of pairs could depend on the
number of contacts the binding peptide makes with the RIIa clan domains. Previous
studies have shown that such a difference exists in the interaction between dual AKAP
(AKAP that interacts with the RIIa domain of both RI-PKA and RII-PKA) and the RIIa
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Figure 3-12. Similarities of the RIIa- and Dpy-30-domain binding sequences.
(A) Alignment of RSP3 sequences with the amphipathic helices that bind RIIa- (AHR) or
Dpy-30-domain (AHD). Paired hydrophobic residues (black boxes) alternate with two varied
residues. No particular residues are conserved to distinguish the two groups of sequences.
D-AKAP2, a dual specific AKAP that binds the RIIa domain in RI and RII of PKA. Ash2
and BIG1, the Dpy-30-binding protein in histone methyltransferase complex and in the
trans-Golgi network. RII-AKAP, Q12802; RI-AKAP, AAC24507 ; C.r., Chlamydomonas
reinhardtii; C.e., Caenorhabditis elegans; D.r., Danio rerio; H.s., Homo sapiens; S.c.,
Saccharomyces cerevisiae. (B) Helical wheel plots of the sequences. The hydrophobic
residues (bold and circled) are clustered to one side of the helix as expected for an
amphipathic helix. AHR and AHD, the RIIa- and Dpy-30-binding sequences in RSP3.
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domain of RI-PKA and RII-PKA. The crystal structures of both these complexes revealed
that the same peptide undergoes one whole helical turn to bind the RIIa domain of RIPKA (Sarma et al., 2010). Thus, in turn, the peptide makes more contacts with residues in
the RIIa domain of RI-PKA.
The binding sites of RIIa domain from RII-PKA and RI-PKA have been studied
extensively. These studies have shortlisted certain key residues that make a binding site
specific for RII-PKA or RI-PKA (Banky et al., 2003; Sarma et al., 2010). In the same
line, the Dpy-30 domain is not well studied and very few Dpy-30 domain binding sites
have been characterized. Thus, it is difficult to compare the Dpy-30 binding sites with the
RIIa binding sites and establish differences between these two domains.
The bioinformatics analysis revealed that similarities exist not just between the
RIIa clan domains but also between the RIIa clan domain binding sites. This establishes
the common binding principle behind these domains. Utilizing a common binding
principle might stem from a common function of these domains which we speculate is
targeting proteins to the appropriate location.

3.4 Discussion
The truncation strategies, using both the in vivo and the in vitro system, reveal the
distinct binding sites for the RIIa and Dpy-30 domain in the RS. These distinct sites are
amphipathic in nature, like all RIIa binding sites within AKAPs. In addition, the mutant
phenotypes from the in vivo system also reveal the molecular interactions of the
sequences tethered to these two domains. These findings elucidate the topology of the RS
and explain the operational mechanism of this complex central for the motility control. In
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addition, the results from the in vitro approach also revealed the common binding
principle for anchoring the similar RIIa and Dpy-30 domains. The evidence and
conclusions from this study are summarized below. The implications of these findings
will be discussed in detail in the final chapter.

3.4.1 RSP3 Contains Binding Sites for the RIIa and Dpy-30 Domain
The in vivo approach which involved generating RSP3 truncation mutants in
Chlamydomonas was utilized to test if RSP3 could directly interact with all four RSPs
with either a RIIa or Dpy-30 domain. The complementary phenotypes of the strains
lacking major parts of RSP3 in the (∆1) and 1-178 strains support this prediction. The
analysis of the truncation mutants also revealed several details pertinent to the
organization of the RS complex. It confirmed that the two RIIa RSPs, RSP7 and RSP11,
are anchored through the AH that is known to anchor RII in vitro (Gaillard et al., 2001;
Yang and Yang, 2006). This showed that these RIIa domains, identified based on
sequence analysis, are functionally equivalent and are used for various molecules, aside
from PKA. In the same token, this could be applicable to the Dpy-30 domain.
Furthermore, the deficiency of armadillo repeat protein, RSP8 (ARM) that interacts with
RSP11, in the ∆1 strain suggests that ARM associates with the coil 1 region of RSP3
either directly or through RSP11. These findings indicate that RSP11, RSP8 and RSP3
may form a tri-molecular complex. Most importantly, these results also suggest that the
interaction between the AH and RSP11 tethers the ARM to RS complex and hence
structurally reinforces the spoke scaffold. The deficiency of RSP7 in the ∆1 strain is
identical to RSP11. Thus these two RIIa proteins are assembled similarly. We speculate
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that RSP7 functions to tether the second ARM-containing RSP, RSP14. However, we
could not verify this prediction due to lack of appropriate antibodies.
Lastly, these results also predicted that the candidate binding site for Dpy-30
domain should be downstream to the AH. Based on the mutants expressing RSP3 varying
at the C-terminus, the Dpy-30 binding region was further delimited to be ~50 a.a. near the
end of the conserved region in RSP3. Furthermore, the spokehead deficiency observed in
these RSP3 truncation mutants is similar to the RSP2 mutants (Huang et al, 1981; PatelKing et al., 2004). This indicates that RSP3 collaborates with RSP2 in linking the
spokehead to the stalk. This confirmed the prediction that RSP2 is not the only molecule
connecting the head and stalk modules together. These predictions were strengthened by
EM of the RS in truncated RSP3 mutants. Together, these findings provide the evidence
for establishing the topography of the RS.

3.4.2 The Topography of the RS
These results combined with the previous finding that RSP3 N-terminus is anchored to
the outer doublets (Diener et al., 1993), support a model wherein dimeric RSP3 forms the
scaffold of the RS complex. The two AHs in each RSP3 monomer anchor a protein with
a RIIa domain and a Dpy-30 domain respectively. This model predicts the topology of
the RS complex which couples the CP to the dynein motors on the outer doublets.
The dimeric core from a single protein extending throughout the RS provides the
backbone to build a rigid complex. Docking of the RIIa domain at the AH at a.a.# 161178 localizes within the RS complex the flanking sequences in RSP7 and RSP11 and the
associated ARM RSPs. These tethered modules could possibly modulate or strengthen

91
the rigidity or other physical properties of the RS for appropriate mechanical transduction
under a wide range of conditions. The docking of the Dpy-30 domain at the downstream
AH at a.a.#280-308 enables the flanking coils in both RSP3 and RSP2 to interact with
each other and to harness the multiple components in the spoke head and spokeneck.
These multiple molecular interactions may be necessary to forge the two modules into
one object that contacts the CP and endures the intermittent force occurring repeatedly
from the mechanical transduction between the CP and the RS. The dimeric nature of
RSP2 and RSP3 (Wirschell et al., 2008) makes it possible to form a symmetric spokehead
that tilts back and forth around the circumference or along the length of the axonemes
during each oscillatory beating. In addition, the docking also localizes the NDK in RSP23
to the neck. The localization of NDK at this position is unclear. However, it seems to be a
valuable strategy since this molecule is also present in mammals. One possibility is that
RS is a measure to distribute the NDK enzyme that balances the concentrations of ATP
and GTP evenly throughout the flagellum. Or the enzymatic activity serves to solely
regulate motility by modulating the local function of the RS or RS/CP system.

3.4.3 The In Vitro System Identified the RIIa- and Dpy-30 Binding Sequence.
Using the in vitro approach, it was possible to confirm that the AH in RSP3 binds the
RIIa domain from RII, RSP7 and RSP11. Most importantly, it also defined the precise
Dpy-30 binding site from the 50-a.a. region as revealed in the Chlamydomonas RSP3
mutants. The Dpy-30 protein from human histone methyltransferase complex helped
circumvent the solubility issues encountered with RSP2 and RSP23 in this system. The
results are justified, as the AHR that was shown to bind recombinant RIIa domain in vitro
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(Gaillard et al., 2001) also bound the RIIa domain of RSP7 and RSP11 (Yang et al.,
2006). The AH for Dpy-30 domains were further confirmed by the V300P mutation.

3.4.4 The Comparison of the RIIa and Dpy-30 Binding Sequences
The well-defined binding sites made it possible to compare the binding sequences for the
RIIa and Dpy-30 domains. The two RSP3 peptide sequences for binding RIIa and Dpy-30
domain were significantly different from each other and from other representative
proteins. However sequence alignment showed that they do follow an identical pattern,
repeats of ΦΦXX, twin hydrophobic residues (ΦΦ) interspersed by paired variable a.a..
Furthermore, the Dpy-30-domain binding helix can be plotted into an AH in a pattern
similar to the RIIa binding sequences. This similar AH pattern is echoed by the similarity
between the Dpy-30 domain and RIIa domain from both RI and RII. Thus, it is rather
interesting that, although the two domains bind to RSP3, especially at two distinct sites,
the principle of the interaction is quite similar if not identical.
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Chapter 4: Development of tools for the study of Dpy-30anchoring mechanism
4.1 Introduction
This thesis and recent findings have demonstrated the similarities of the Dpy-30 and RIIa
domain in sequence, structure and function (Chapter 3). Each domain is present in over
200 molecules that have additional diverged molecular architectures. These molecules
mediate vital processes ranging from flagellar motility to membrane trafficking to
epigenetic regulation. Like RII that binds many AKAPs, Dpy-30 protein itself binds to at
least two vital molecules, BIG1 in the Golgi apparatus and Ash2 in histone
methyltransferase complexes in the nucleus (Xu et al., 2009; Cho et al., 2007). The
binding of human Dpy-30 protein to the Dpy-30-domain-binding AH in the radial spoke
(RS) demonstrated the functional equivalence of these domains. Collectively, these
findings raise three important questions. First of all, do the RIIa and Dpy-30 domains
demonstrate specificity in terms of their binding partners? Secondly, aside from BIG1
and Ash2, how many more molecules anchor Dpy-30 proteins in various cells and
organisms? Lastly, could the new findings on the Dpy-30 domain be applied for other
research and therapy, such as the identification or perturbation of other anchoring
proteins?
Similar questions have been thoroughly explored for the RIIa domain, cAMPdependent protein kinase A (PKA) and numerous A-kinase anchoring proteins (AKAPs).
The explosive discoveries in this field heavily relied on several powerful tools. The
development of the labeled RII, a high-affinity blocking AH and the RII overlay
catapulted the study of AKAPs and the differential targeting of RI type PKA and RII type
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PKA. Similar tools for the Dpy-30 domain will likely simplify and accelerate the research
of this domain and its anchoring proteins.
This dissertation has highlighted the insight that could be gained from exploring
the anchoring proteins of Dpy-30 domain. As described in Chapter 3, identification of
RSP3 as the anchoring protein for the Dpy-30-domain-containing RSP2 and RSP23 led to
the elucidation of the molecular topography and mechanism of the RS. The reagents
designed for these experiments could be modified into new tools towards understanding
the Dpy-30 proteins and its molecular interactions.
Initially, recombinant human Dpy-30 and the RIIa domain that bind to the
respective GST-tagged AHs could be used to test cross reactivity and to design the firstgeneration overlay assay. Subsequently, the existing constructs could be modified by
adding different tags depending on the requirement of each assay. Each assay has distinct
advantages and some of these assays need to be sensitive and quantitative. These new
tools will pave the way for the development of specific and high affinity blocking AHs.
The preliminary data for these assays will be described in this chapter.
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4.2 Results
The ultimate goal is to develop simple assays for identifying various proteins that anchor
the Dpy-30 domain and high affinity AHs that block the interaction. These two goals are
related. Simple assays will help the development of high affinity AHs. Conversely, high
affinity AHs can verify the specificity of the interaction between the anchoring proteins
and Dpy-30 in the assays. Studies on the Chlamydomonas flagellar RS complex
described in Chapter 3 defined the RIIa and Dpy-30 binding AH in RSP3. These results
were exploited to establish three strategies described below.

4.2.1 Strategies to Identify Dpy-30 Interacting Polypeptides
Three strategies were taken to identify Dpy-30 interacting polypeptides: affinity copurification, native gel electrophoresis; and a Dpy-30 overlay. All three methods can be
used to test candidate Dpy-30 binding polypeptides. The overlay can be used to screen
unknown samples.

4.2.1.1 Affinity Co-Purification
This method relies on the interaction of two recombinant proteins that are co-expressed in
bacteria; or expressed separately but mixed together once bacteria are lysed. This method
has been used extensively in the study for PKA and AKAPs (Carr and Scott, 1992) and in
this dissertation to identify the RIIa and Dpy-30 binding sites in RSP3. Specifically, Histagged RIIa clan proteins and GST-tagged RSP3 peptides were co-expressed in bacteria
and were pulled down together by Ni-NTA affinity chromatography. Alternatively, they
could also be pulled
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Figure 4-1. The Dpy-30 domain cross-reacts with the AHR.
(A) His-tagged Dpy-30 protein (arrowhead) or (B) His-tagged RIIa domain
from RSP7 (arrowhead) were co-expressed with GST tagged AHR or AHD
respectively (dot). The Ni-NTA pull-down was analyzed by Coomassie
stained protein gel. While the AHR (dot in A) cross-reacted with the Dpy-30
protein, the AHD (dot in B) did not bind to the RIIa domain from RSP7. Pre,
the bacterial extract; Post, the flow through from Ni-NTA matrix; and E, the
eluate.
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down by glutathione-agarose that binds GST. The reciprocal co-purification of the GSTtagged RSP3 peptides along with the His-tagged RIIa clan proteins indicate the ability of
these two proteins to interact.
To test if the two sets of AHs and the RIIa clan domains cross-react, His-tagged
Dpy-30 and GST-tagged AHR were co-expressed in bacteria. Although AHR binds the
RIIa domain in vivo, it also co-purified with Dpy-30 (Figure 4-1A). This indicates the
similarity and the identical binding principles of these two domains. However, the cross
recognition is not universal, since it was not observed in the reverse experiments. The
RIIa domain from RSP7 was not pulled down by the GST-tagged AHD that binds Dpy-30
domain in vivo (Figure 4-1B). The selective cross reactivity is interesting. One possibility
is that certain AHs or RIIa clan domains have broad recognition because of their amino
acid residues. Alternatively, the cross recognition may be due to the contour of the
binding surfaces. The binding cavity in the dimeric RIIa domain tends to be shallower
than the Dpy-30 domain and RI’s RIIa domain.
This experimental strategy allows us to test the interaction between various
combinations of anchoring proteins and docking domains.

4.2.1.2 Native Gel Electrophoresis
The disadvantage of the pull-down assay is that the two proteins to be tested must have
different tags. This limitation could be circumvented by native gel electrophoresis that
fractionates protein complexes and is tag-independent. However, the two proteins to be
tested need to be purified.
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To test the principle, Dpy-30 protein was mixed with the two AHs in RSP3: AHR
at a.a.# 161-178, that interacts with the RIIa domain in vivo; and AHD at a.a.# 280-308,
that binds to the Dpy-30 domain in vivo. Both AHs were tagged with GST. Also tested
was a peptide within the Dpy-30-binding sequence in Ash2, the physiological partner of
Dpy-30 protein in the Set-1 methyl transferase complex (South et al., 2010). The peptide
was predicted based on its secondary structure and three units of ФФXX that is typical of
the RIIa-clan- binding AHs. Ash2 peptide was tagged with GFP and a His tag at the N
terminus. The advantage of GFP is its monomeric nature while GST is inherently
dimeric. Secondly, GFP fluoresces and this fluorescence can be used as a reporter for a
one-step quantitative assay. However, GFP is not conducive for affinity purification
hence a second tag, 8 His in this case, was added for affinity purification.
His-tagged Dpy-30 and His-tagged GFP-Ash2-AHD proteins were purified using
Ni-NTA. The GST-RSP3-AHD polypeptides were purified using glutathione-agarose.
Equal amounts of each tagged AH and purified Dpy-30 were mixed together. Following
1-hour incubation, the samples were fractionated on a native gel and visualized by
Coomassie stain (Figure 4-2). As protein complexes remain intact in native gels, an
interaction between Dpy-30 and tagged AH would result in a shift in the band size as
compared to the control samples that contained only one protein.
The results showed that all mixtures contained new bands distinct from the bands
of the individual molecules (Figure 4-2). This showed that Dpy-30 forms a complex with
AHD at RSP3280-308 as expected and with the predicted AHD in Ash2. This is the third line
of evidence that the Dpy-30-binding sequences contain triple or quadruple units of
ФФXX a.a., just like the RIIa-binding sequences. In addition, Dpy-30 also binds to AHR
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that binds the RIIa domain, as shown in the pull-down assay (Figure 4-1A). Thus this
method and the pull-down assay are suitable to test the interaction between anchoring
motifs and docking domains.
Notably, Dpy-30 band shifts in opposite directions when complexed with GSTtagged or GFP-tagged AHD. When Dpy-30 is allowed to interact with the AH tagged to
GST that is a dimer, the Dpy-30 oligomers become smaller, slightly bigger than GST
tagged-AHs. In contrast, Dpy-30 actually shifted upwards when it forms complex with
Ash2-AHD that is tagged to the monomeric GFP.
The opposite shifting directions could be due to the differences in tags or AHD.
Although Dpy-30 is assumed to function as a dimer, purified Dpy-30 domain forms
tetramers and higher-ordered oligomers (Dong et al., 2005; Wang et al., 2009). Dimeric
GST-tagged AHs may dissociate Dpy-30 oligomers into dimers. The dimeric tag could
potentially influence the kinetics of the molecular interaction. To test this, the native gel
assay could be conducted to compare two fusion proteins with the same AHD but tagged
to GFP or GST.
In summary, native gel electrophoresis is a rather straight forward assay for
testing the interaction between purified Dpy-30 and candidate target proteins. The
resolution of monomers and complex depends on the band shift. However, the shift in
this case is sufficient and the method is easy and economical. However, the migration
patterns could be influenced by tags and hence it is important to use the same tag when
comparing the kinetics of different AHs for Dpy-30.
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Figure 4-2. Native gel electrophoresis for identifying Dpy-30-binding
peptides.
GFP-tagged Ash2 and GST-tagged RSP3 peptides purified from bacteria were
mixed with purified Dpy-30 protein (dot represents the tetramer) and fractionated
on a native gel. AH, amphipathic helix; D, Dpy-30 binding AH in RSP3; R, RIIabinding AH in RSP3. Polypeptides were revealed by Coomassie stain.
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4.2.1.3 Overlay
Compared to the previous two assays, overlay is extraordinarily simple and versatile. It is
analogous to a far western assay. Both use a protein ligand as a probe to detect its binding
partners on the blot. The ligand can be labeled, for example with radioisotope, biotin or
enzymes to aid in the detection. Or the ligand, as in far western assays, could be
visualized indirectly through antibodies. These methods have been used successfully to
study the interaction between RII and AKAPs (Lohmann et al., 1984).
In particular, 32P-labeled RII was often used as a ligand to identify AKAPs in
different biological systems. The protein samples are separated on SDS-PAGE gels and
transferred to a nitrocellulose membrane. Subsequently the membrane is probed with 32Plabled RII and the AKAP bands are revealed by autoradiography or a phosphorimager.
The ligands can recognize other non-AKAP bands as well. In order to identify AKAPs
that interact with RII through the AH and RIIa domain, the control experiment is carried
out in the presence of Ht-31, a synthetic peptide derived from the AH of AKAP-Lbc.
This peptide has a high affinity for RII and acts as a competitive inhibitor. In theory, a
protein that binds RII in an AKAP specific manner will not bind to RII in the presence of
Ht-31.
We have tested an overlay, in fact a far western assay, using Dpy-30 as the ligand.
In theory, this assay would aid the identification of Dpy-30 binding proteins in various
protein samples (Figure 4-3). Axonemes from WT and spokeless pf14 strains were
fractionated in an SDS PAGE gel and transferred onto a nitrocellulose membrane (Figure
4-4A). The membrane was probed with 1 µg/ml purified Dpy-30 protein. The blot was
then probed with α-Dpy-30 antibody followed by the secondary antibody. The assay
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revealed a band which was present in WT axonemes but absent in pf14 (Figure 4-4A).
This suggested that it is a radial spoke specific band. The size of the band suggested that
it is RSP3. To test this, the overlay was re-probed with anti-RSP3 antibody (Figure 44A). Indeed anti-RSP3 decorated the band picked out by the overlay assay. Interestingly,
the antibody also recognized a slightly smaller band corresponding to the hypophosphorylated RSP3 (Qin et al., 2004). This suggests that Dpy-30 only binds to the
phosphorylated form of RSP3. To differentiate if the bands revealed in the overlay is due
to Dpy-30 and not due to the antibodies directly, a control blot was only probed with antiDpy-30 and the secondary antibody only. As predicted, the control blot did not reveal
RSP3. It remains to be determined whether Dpy-30 binds to RSP3’s AHD or AHR in the
overlay assay.
The overlay assay was also used to probe the bacterial extract that contains GSTtagged AHD (RSP3269-316) and AHR (RSP396-180) separated on a SDS-PAGE gel. The
Dpy-30 protein was shown to bind both AHs (Figure 4-4B). This further confirmed the
cross-reactivity of AHR and Dpy-30. However, the antibodies that were raised against
proteins purified from the bacterial extract generated undesirable backgrounds in the
bacterial samples. This problem could be overcome by using purified protein samples or
a different read out that does not depend on antibodies.
Using the well characterized axonemal samples and defined bacterial extract, we
showed that Dpy-30 is suitable as a ligand for the overlay assay. Similar to RII overlays,
we envision that this Dpy-30 overlay is an amenable tool for testing various protein
samples. The next step is to develop a high affinity AH as a blocker, analogous to Ht-31
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Figure 4-3. Schematic depicting the Dpy-30 overlay procedure.
The top panel depicts the overlay strategy and the bottom panel depicts the
negative control blot that reveals Dpy-30 specific interactions.
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Figure 4-4. The Dpy-30 overlays.
(A) Blots of the axonemes from WT and the spoke-less pf14 were probed for Dpy-30
protein, anti-Dpy-30 and the secondary antibodies (left panel). A band of the size of
RSP3 in WT axoneme and absent in pf14 was decorated (arrow). To test if the band is
RSP3, the overlay blot was re-probed with α-RSP3 antibody (right panel). As
expected, RSP3 antibody recognized two bands as RSP3 is a phosphoprotein. Note the
upper band that was more phosphorylated (asterisk) was decorated in overlay. This
suggests that phosphorylation of RSP3 promotes Dpy-30 binding. The control blot of
axonemes was probed with anti-Dpy-30 and the secondary antibody without Dpy-30
(middle panel). (B) The Dpy-30 overlay of the bacterial extract containing GST-AHD
(RSP3269-316) (arrowhead, left panel). The control blot was probed with anti-Dpy-30
and the secondary antibody only (middle panel). The bacterial extract GST- AHR
(RSP396-180) that binds RIIa domain was decorated by Dpy-30 overlay. Thus Dpy-30
protein cross-reacts with AHR in the overlay.
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for the RII overlay. Preferably, this AH could block the binding of Dpy-30 to AHD, but
not AHR.

4.2.2 Development of Quantitative Assays
All three methods developed in this dissertation are suitable for the discovery of new
Dpy-30-domain anchoring proteins. Each method has its own advantages and
disadvantages. The common result is that Dpy-30 cross-recognizes AHR. However, the
RIIa domain does not seem to recognize AHD. The deeper pocket of dimeric Dpy-30 may
associate with AH with less stringency. The common limitation for these three methods
mentioned above is that they are excellent for qualitative studies but cannot reveal
quantitative data. They show either a positive or negative interaction but cannot
differentiate the affinity of the AHs for Dpy-30. It is critical to develop a quantitative
assay that could quantify the affinity of the AH-D/D interactions and identify a high
affinity AH that would serve as a blocker for overlay and other studies.
The high affinity peptide blockers for Dpy-30 are analogous to Ht-31 for RII. This
peptide would act as a competitive inhibitor that disrupts proteins interacting with Dpy30. We postulate that the AHD in RSP3 binds Dpy-30 with a stronger affinity than the
AHD in Ash2, because the radial spoke complex is an extraordinarily stable complex that
can resist upto 0.6 M potassium iodide.

4.2.2.1 GFP as a Reporter for a 96-Well Plate Assay
For high throughput assays of Dpy-30-binding sequences, one way is to immobilize Dpy30 directly to the wells or indirectly through antibodies (Figure 4-5A). Then the wells can
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be incubated with AHD tagged to a polypeptide that will aid the read out, like GFP. For
demonstration, the AHD from Ash2 was fused to GFP; this fusion protein can bind to
Dpy-30 in the native gel (Figure 4-2).
The purified GFP-AHD was first quantified by Bradford protein assay. To test if
GFP releases enough fluorescence to be a sensitive reporter, different amounts of GFPAHD was added into each well and the light emitted after excitation was measured with a
fluorescence microplate reader. The GFP was excited at 480-nm and the emission was
measured at 510 nm (Figure 4-5B). The relative light intensity was plotted against the
amount of the total GFP-AHD added. Unfortunately, 5-10 µg of GFP-AHD is necessary to
obtain a reliable signal above the threshold level. Amounts less than that resulted in
negative readouts or a high signal to noise ratio. Thus GFP-based assay is at least 1000
fold less sensitive than ELISA that can detect less than 5 ng of molecules (Dixit et al.,
2010). Thus although the yield of recombinant GFP-AHD is high and the readout is very
convenient, the fluorescence emitted per GFP is insufficient for a sensitive assay.
Several parameters need to be established for a quantitative 96 well assay. One is
to use different reporter systems, such as anti-GFP and chemiluminescence; or luciferase
and luminescence. The former requires two steps of antibody incubations, while the latter
allows direct measurement. However, the reagents for the luciferase assay are more
expensive and have a shorter life span. In addition different types of 96 well plates need
to be tested. Currently, only the high absorbance plate was tested. The preliminary data
for ELISA revealed undesirably high signal to noise ratios. It may be necessary to test
different types of 96 well plates for each output.
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Figure 4-5. Developing Quantitative assays to test the affinity of Dpy-30 binding
peptides.
(A) Schematic depicting the fluorescence based quantitative assay to measure the
affinity of Dpy-30-binding peptides. (B) The light emitted from the bound GFPtagged-Ash2 AHD. FU: Fluorescence Unit.
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4.2.3 Screening Non-Peptide Blockers for Dpy-30
High affinity blockers, like Ht-31, play a crucial role in RII overlays that identify AKAPs
based on the AHR-RIIa interaction. However RII also interacts with proteins through undetermined interactions. Thus, in order to identify proteins that bind RII in an AKAP
specific manner, high affinity blockers like Ht-31 are employed. Proteins are recognized
as AKAPs if their interaction with RII is competitively blocked by Ht-31. Thus, a high
affinity AH is instrumental to determine the specificity of the interactions in vitro. Aside
from overlays, the high affinity AHs and its membrane-permeable variants have been
widely used for functional perturbations in various studies. Recently, small organic
compounds were found to block the AKAP-RII interaction in ways similar or distinct
from Ht-31 (Klussmann et al., 2006; Christian et al., 2011). Although the specificity of
these compounds remain to be assessed, both peptide and non-peptide blockers could be
potentially useful for perturbing the Dpy-30 and AHD interaction.

4.2.3.1 Screening Chemical Blockers with Native PAGE
The Dpy-30 and AHD interaction discovered in this thesis was used to test the feasibility
of screening chemical inhibitors. This is a collaborative effort with the lab of Dr. Daniel
Sem in the Department of Chemistry at Marquette University. An in-silico analysis using
the AutoDock software was first conducted to align the crystal structure of the dimeric
Dpy-30 domain with 10,000 compounds in a chemical library.
Ten compounds that could best fit in the binding cavity of the dimeric Dpy-30
domain were identified. The effects of these compounds in perturbing the association
between Dpy-30 and an AHD was revealed by native gel and pull-down assays (Figure 4-
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4 and 4-5). GFP-Ash2-AHD was used in this assay, since if the assay is successful, the
compound could be used to perturb the interaction of Dpy-30 and Ash2 in histone
methyltransferase complex.
An aliquot of 2 µg of Dpy-30 protein was incubated with 25 µM compound for 1
hour at room temperature. Subsequently, GFP-Ash2-AHD was added into the mixture.
The reaction mixture was then fractionated on a native gel and revealed by Coomassie
stain (Figure 4-6). If a compound blocks the interaction between Dpy-30 and GFP-AHD,
these two molecules will migrate as individual molecules in the native gel rather than a
complex. Complex formation was assessed based on the appearance of new bands in the
combined sample (Figure 4-6) and the reduced intensity of individual molecules. A
sample without chemical compounds served as the negative control. The results showed
that the predicted AHD from Ash2 binds to Dpy-30 in the presence of all the compounds.
Thus none of the candidate compounds identified by the in-silico analysis were able to
compete with AHD in Dpy-30 binding.
Despite the negative result, this simple assay in theory could be used to identify
high affinity compounds or AH peptides. However, this assay has several drawbacks. The
number of samples that can be tested in each gel limits the number of compounds that can
be screened. Thus this method could be used after candidate compounds are identified but
not for a high-throughput assay. A larger chemical library with compounds of more
diverse chemical properties than the current one may provide more candidates. Secondly,
the Coomassie-stained output is not sensitive and thus a large quantity of compound is
required for the assay. In addition, the first generation compounds may not have enough
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Figure 4-6. Screening a library of compounds using the native gel assay.
His-tagged Dpy-30 purified from bacteria was incubated with different compounds.
Purified Ash-2 was subsequently added to the mixture and fractionated on a native gel.
A mixture that did not contain any compounds served as the negative control. The
numbers depict the different compounds. The arrow represents the Dpy-30 tetramer,
the arrowhead represents the complex of Ash-2 and Dpy-30.
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affinity for competition, if the affinity of Ash2-AHD for Dpy-30 is high. The dissociation
constant, Kd of Ash2 and Dpy-30 is about 100 nM (Patel et al., 2009).
4.2.3.2 Screening Chemical Blockers with Co-Purification
The compounds were also assessed by co-purification of His-tagged Dpy-30 and GSTAHR (RSP396-180) (Figure 4-7). AHR, instead of AHD, was chosen because AHR may have
lower affinity for Dpy-30 and the interaction could be more easily blocked by chemical
compounds. If a compound could block the interaction, GST-AHR will not be co-purified
with His-tagged Dpy-30 protein by Ni-NTA.
10 more compounds identified by in-silico analyses were tested with this method.
Aliquots of His-tagged Dpy-30 protein pulled down by Ni-NTA was incubated with 50
µM candidate compounds for 1 hour at room temperature. Subsequently, GST-AHR
(RSP396-180) was added into the mixture. After one-hour incubation, the mixture was
subjected to Ni-NTA and the flow through was collected. The samples of the input and
the flow through were fractionated on an SDS PAGE gel and revealed by Coomassie
stain (Figure 4-7). If the compound was able to perturb Dpy-30-AH interaction, the RSP3
peptide in the flow through would be higher than that in the control without any
compounds.
The results revealed that the amount of unbound RSP3 peptide did not differ significantly
between the experimental and the control sample (Figure 4-7). Although none of the
compounds could serve as competitive inhibitors, this method is feasible and rather
simple like the native gel assay. However, both methods suffer from the same limitation
in sensitivity, qualitative results and the throughput levels. It also requires additional
steps in pull-down and the amount of Ni-NTA matrix added to each reaction can vary
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Structure

Assigned
Name

Chemical Name

3027 (b)

3-[(dimethylamino)methyl]-1,3benzoxazol-2(3H)-one

10173 (d)

3-Phenylproline

1059 (f)

3-Cyanobenzoate

1830 (g)

1H-benzimidazol-2ylmethanaminium

2027 (h)

2-[(furan-2ylcarbonyl)amino]ethanaminium

2908 (c)

5-(4-fluorophenyl)tetrazol-1-ide

9606 (e)

2-(piperidin-1-ylmethyl)phenol

4046 (i)

3-phenyl-N-(2H-tetrazol-5yl)propanamide

8075 (a)

1-phenyl-1,2-dihydro-5Htetrazole-5-thione

Table 4-1. List of Chemical compounds
The table showcases the structures and chemical names of the
organic compounds used in the screening. The number in the
assigned name column was designated by Dr. Sem’s lab and the
letters correspond to those used in Fig 4-7.
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Figure 4-7. Pull-down assay for screening organic compounds.
Purified His-tagged Dpy-30 was incubated with different compounds first and the Dpy30-binding peptide, RSP396-180. The mixture (pre) and the flow through (post) from NiNTA affinity chromatography were assessed by SDS-PAGE to test if any compound
inhibited the interaction of Dpy-30 and RSP396-180. The control lanes are samples
without any compounds. The letters depict the different compounds that were tried.
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easily during experimentation.
4.3 Discussion
The preliminary studies described in this chapter explored the interactions between the
Dpy-30 domain and its binding AHs in the existing anchoring proteins. The reagents and
assays developed here demonstrate the direction for future studies. The improved tools
will be invaluable for studying the emerging proteins in the RIIa clan and the molecules
that anchor these novel proteins.
Taking advantage of the existing reagents, the various assays revealed the crossreactivity of the Dpy-30 domain and AHR that is supposed to bind the RIIa domain. This
is not particularly surprising given the similar secondary and tertiary structures of these
domains. However, this finding leads to the question of how AHR and AHD in RSP3 bind
to the respective RIIa- and Dpy-30 domain containing RSPs. In addition, how do the
numerous anchoring molecules with various AHs in the cell body interact with only the
right partners in the cell body? Several possibilities are proposed and will be dealt with in
Chapter 5.
The preliminary data revealed the reagents and methods that could be used for the
study of Dpy-30 domain and its interactions with various anchoring proteins. Each assay
has advantages and drawbacks. Most of them are feasible but need to be optimized. One
important contribution of this study is the use of Dpy-30 as a ligand in the overlay. As
Dpy-30 exhibits cross-reactivity for AHR that binds the RIIa domain, it is possible that
the Dpy-30 overlay can replace RII overlay for a broad spectrum screening of anchoring
proteins. To further differentiate the RIIa binding proteins, a duplicate blot could be
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processed for RII overlays with and without Ht-31 blockers. The bands that are only
recognized by Dpy-30 could be the anchoring proteins for Dpy-30 domains. Those
recognized by RII and Dpy-30 could be the anchoring proteins with AHR or with both
AHR and AHD, like RSP3. It is also desirable to modify the AHD into a specific peptide
blocker that competitively inhibits binding with Dpy-30 domain while not affecting the
binding with RIIa domain.
To develop high affinity AH as blockers, it is preferable to develop quantitative
assays to determine the affinity of the existing AHD for the Dpy-30 domain. The AHD
with the highest affinity can be used to devise additional peptides with even higher
affinity. If the quantitative assay is sensitive and high throughput, it could be used in the
screening of chemical libraries. Other strategies for developing peptide variants could be
considered. For example, peptide arrays have been commonly used in the development of
high affinity binding peptides. A spectrum of peptides, in which each residue is replaced
by every possible a.a., are spot synthesized into a chip-like matrix. The matrix could be
probed with ligands, like RII or Dpy-30 in the overlay assay. While some peptides lose
the ability to bind the ligand, some others have higher affinities. This unbiased screening
strategy led to the discovery of several AHs that bind RII with affinity 5 -10 fold higher
than physiological AKAPs (Alto et al., 2003; Burns-Hamuro et al., 2003; Gold et al.,
2006). These super AHs can also be further modified to be specific for RII or RI. In
addition, this exhaustive technique also can reveal considerable information about the
role of each amino acid in the AH. This peptide array is worth considering for developing
tools to study the Dpy-30 domain.
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Chapter 5: Discussion
This dissertation set out to discover how an axonemal complex that controls flagellar
motility accommodates two pairs of proteins that contain similar RIIa clan domains. The
results revealed that the two types of RIIa clan domains, RIIa and Dpy-30, dock to two
similar AHs in a dimeric protein, RSP3. These conclusions support a new model that can
explain the assembly and function of the RS. They also suggest that the AH and D/D
domains constitute a localization mechanism for a spectrum of effector mechanisms
much broader than PKA. These findings not only question the existing concepts of these
molecular modules but also raise intriguing queries that remain to be investigated. The
tools developed in this dissertation could be used to make headway into future studies.

5.1 A New RS Model
Both in vivo and in vitro evidence support a model that the RSP3 dimer extends
throughout the spokestalk with two discrete regions for anchoring the two types of D/D
domains in four RSPs. A region near Coil 2 anchors the Dpy-30 domain present in RSP2
and RSP23. The helices downstream to the binding region in both RSP2 and RSP3 may
form coiled coils with each other and with the head components. As for RSP23, the Dpy30 domain could tether the associated NDK activity to the RS complex (Patel-King et al.,
2004). Finally, the spoke-specific HSP40 (RSP16) is added to this region (Yang et al.,
2008). Through these multiple interactions, the head, neck and stalk are linked together as
a single unit that can couple the CP and outer doublets at a high frequency.
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Spoke Head

CP

Figure 5-1. The new RS model.
Schematic depicting the topology of the radial spoke complex. RSP3 dimer of the
conserved region forms the stalk scaffold (black and grey lines). The N terminus of
RSP3 docks 5 LC8 molecules (pink ovals) (Gupta et al., unpublished). The AHR
docks the RIIa-domain containing proteins, RSP7 (orange and red spheres) and
RSP11 (yellow and mustard spheres). The binding of these proteins in turn tethers
the associated effector mechanisms, the calcium binding motifs (green circles) of
RSP7 and the armadillo (ARM) repeat protein (RSP8, light pink oval) which binds
to RSP11 and the coil1 region in RSP3 and enhances the rigidity of the spoke stalk.
The Dpy-30-domain containing proteins dock onto the downstream AHD. Both RSP2
and RSP23 form part of the neck sub-complex and helps to link the spoke head and
spoke stalk modules. CP, Central pair apparatus; NDK, Nucleoside Diphosphate
Kinase domain; D, Dpy-30 domain; R, RIIa domain; ARM, ARMadillo repeat
protein.
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The RIIa domain of RSP11 docks onto the AHR in RSP3 while the short flanking
sequence tethers the armadillo repeat protein, RSP8 to interact with the Coil 1 region in
RSP3 directly or indirectly. We speculate that this may enhance the rigidity of the
dimeric RSP3 core, since the mutants defective in RSP11 can swim but become
paralyzed in the exhausted media (Yang and Yang, 2006). By the same token, RSP7’s
RIIa domain docks to the same AHR in the other RSP3 monomer. Yet contrary to the
constitutive function of RSP11, RSP7’s EF-hands are in position to allosterically
modulate the stalk when calcium increases, in a way analogous to the cAMP-induced
allosteric release of the PKA catalytic subunit.
The various functions of these four RSPs are all docked through the D/D domains
to the two AHs in RSP3. As RSP3 N-terminus associates with the microtubule outer
doublets in the axonemes (Diener et al., 1993) while the C-terminus is involved in the
spokehead assembly, the dimeric RSP3 clearly is a bona fide core scaffold of the entire
complex. The RSP3 sequence also supports this new RS model. The spoke stalk length
has been proposed to be around 38-41 nm by studies of axonemes prepared and
visualized by different methods (Nicastro et al., 2005; Yang et al., 2001). Although
Chlamydomonas RSP3 is 516 a.a. in length; sequence homology and functional studies
have shown that the C terminal region is dispensable (Diener et al., 1993). This study
further defined that 1-316 a.a region of RSP3 is the smallest essential region.
The N terminus of this essential region contains 5 LC8 binding sites and has been
shown to bind LC8, a small ubiquitous molecule that functions as a dimer (Gupta et al.,
unpublished). Five LC8 molecules span a distance of 20 nm (Stelter et al., 2007). The rest
of the conserved region is mainly coiled coil in nature (Fig 3-1 B). Considering the rise
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per residue along a straight α-helix is 0.15nm (Lim et al., 1951), this region between 161
and 316 a.a would span a distance of 23 nm, bringing up the entire spoke stalk length to
~43 nm which is very close to the current estimate. Thus RSP3 can span the spoke stalk
distance, supporting this complex that regulates oscillatory beating mechanically and
chemically.

5.2 Versatility of the AH-D/D Localization System
The interactions of AHR in RSP3 with RII in vitro (Gaillard et al., 2001) but with nonPKA RSP7 and RSP11 in vivo further confirms the predicted functional equivalence of
these domains (Yang and Yang, 2006; Newell et al., 2008). This equivalence is also true
for human Dpy-30 protein in histone methyltransferase complex. Dpy-30 binds to Ash2
in the histone methyltransferase complex in vivo (Roguev et al., 2001; Dehe et al., 2006)
but recognizes RSP3’s AHD that binds the Dpy-30 domain in RSP2 and RSP23 in the RS
complex.
Contrary to the conserved anchoring and docking domains, the effector
mechanisms may not be evolutionarily conserved. The RIIa clan members are drastically
diverged. The orthologues of these four members in Chlamydomonas RS are not evident
in other organisms even though RSP3 orthologues, including the anchoring AHs, are
conserved. The orthologous RIIa clan members contain the RIIa clan domains but differ
in the nature of the associated flanking sequence. The conserved localization mechanism
but divergent effector mechanisms may be an evolutionary scheme to tailor the motility
control to suit the special needs of individual cell types in different environments. For
instance, calcium and cyclic nucleotides induce motility changes in virtually all motile
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cilia and flagella. However each cell type responds differently to these second
messengers (Smith and Yang, 2004). Perhaps for different organisms, the second
messengers act on the diverged RIIa clan members, including RI or RII, in the RS to
induce different motility changes. As motile cilia and flagella are critical for the survival
of individual species, these diverged effector mechanisms may have evolved
independently and those that give individual species advantages in their respective
environment are retained. Thus AHs and D/D domains constitute a versatile system to
anchor various effector mechanisms beyond PKA.

5.3 The AH Molecular Scaffolds
This study shows that, although D/D domains can anchor various effector mechanisms,
the molecules with AHs may largely serve as scaffolds of molecular complexes. AKAPs
are signal transduction scaffolds that anchor multiple molecular switches and PKA via
the AH-D/D interaction (Wong and Scott, 2004). This dissertation shows that RSP3, once
known as AKAP, is indeed a signal transduction scaffold as it anchors effector
mechanisms like RSP7’s EF hands that transduce calcium signals. However, the term
signal transduction scaffold falls short of depicting the essence of RSP3 which is to
support the entire RS complex structurally. Furthermore, some effector mechanisms
anchored to RSP3’s AHs are for the assembly or constitutive enhancement of this
structural complex. Hence RSP3 is both a structural and signal transduction scaffold.
Recognition that proteins with AHs could serve as structural scaffolds is
important to understand the molecular complexes with AH-containing anchoring
molecules. The usage of AH-D/D interaction in building up a structural scaffold may not
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be unique to RSP3, the RS or flagella. The same could be true for Ash2, a component in
the Set 1-like histone methyl transferase complex. Ash2 interacts with Dpy-30 in the core
complex in various Set1-like histone methyltransferase complexes (Patel et al., 2009;
Cho et al., 2007). Both molecules are important for the enzymatic activity, albeit in
different ways (Patel et al., 2010). Ash2 is vital for the enzymatic activity while Dpy-30
is not. Yet Dpy-30 affects the H3K4me3 level across the entire embryonic stem cell
genome (Jiang et al., 2011). Aside from Dpy-30, Ash2 also associates with RbBP5, a
WD-repeat protein subunit in the core complex (Patel et al., 2009). It is possible that
Ash2 serves as a structural scaffold of this complex that transfers methyl groups.
The other examples are BIG1 and BIG2, the paralogous guanine nucleotide
exchange factors in the trans-Golgi network. These two large molecules interact with
each other. BIG2 also contains three AHs that can interact with RI or RII in vitro (Li et
al., 2003), whereas BIG1 contains an AH that anchors Dpy-30 in vivo (Ishizaki et al.,
2006; Xia et al., 2010). In addition, each of them also associates with other molecules
that mediate critical functions related to membrane trafficking. This heterodimer, like the
RSP3 homodimer, may form a hybrid scaffold for structural and signaling purposes.
Thus, it is possible that the molecules that utilize AH for anchoring a variety of
the RIIa clan molecules with D/D domains are molecular scaffolds in general. Some are
strictly for forming the structural backbone of molecular complexes; some anchor
molecular switches for signal transduction and the others have combined features. The
term AKAP is appropriate for those molecules that actually anchor PKA yet misleading
for those that do not like RSP3. Therefore, we propose to use D/D-domain Anchoring
Proteins (DAPs) to designate the molecules that utilize AHs to anchor myriads of

122
functions tethered through a D/D domain. It would be apt to refer to AKAPs as a subfamily of DAPs that specifically anchor PKA in vivo.

5.4 The Conservation and Divergence of the AH-D/D System
We expected that the sequences for anchoring the RIIa and Dpy-30 domains are specific
and significantly different for three reasons. These two domains are present in the same
complex. Furthermore, the residues and the length of helices in the two domains are
diverged enough to be classified into two families. Lastly, the N-termini in these two
domains that contact binding peptides are distinct (Wang et al., 2009). Yet the AHR for
the RIIa domain and the AHD for Dpy-30 domain are similar in their sequence pattern
and binding principle, and are present in the same molecule, RSP3. And interestingly, the
similarity is high enough that AHR and Dpy-30 bind in the in-vitro setting.
The cross reactivity indicates that RIIa and Dpy-30 domains are more similar than
expected. This notion prompted us look into the RIIa variant—the RIIa domain from the
RI subunit of PKA. Interestingly, the N-terminus of Dpy-30 and RI’s RIIa domain are
both helical (Banky et al., 2003; Wang et al., 2009; Sarma et al., 2010). In contrast to the
β-strand in RII’s RIIa, the N-terminus of both RI’s RIIa and Dpy-30 forms an α-helix
that contributes to a deeper pocket for the AH (Banky et al., 2003; Sarma et al., 2010).
Their structural alignment appears equal to, if not greater than, the alignment of Dpy-30
and RII’s RIIa domain (Wang et al., 2009). Thus, although the N-terminus of the RIIa
clan domains is critical for binding to an AH, it is insufficient to drastically change the
interacting peptide sequences. Despite the classification of the RIIa clan into two
families, the principle of molecular interactions for the two D/D domains is identical. The
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strong resemblance is resonated by the cross-recognition between the Dpy-30 domain and
the AHR.

5.5 Selective Cross-Reactivity of the AH and D/D Domain
The similarities between both the AH and D/D domains is reflected in the in vitro
recognition of the AHR by Dpy-30 as well as RIIa from RSP7 and RSP11. Yet, AHD
binds to Dpy-30 alone and not the RIIa from RSP7 in either the pull down or the overlay
assay (Gaillard et al., 2001).
However, it is premature to generalize that only AHR and Dpy-30 have cross
reactivity or this cross reactivity is due to unique structural features. It has been
demonstrated that some AHs are mono-specific, binding to either RI or RII but not both
(Angelo and Rubin, 1998; Hirsch et al., 1992), whereas certain AHs, from dual-specific
AKAPs, recognize both RI and RII (Huang et al., 1997; Wang et al., 2009; Li et al.,
2003). In this regard, the AHR in RSP3 is a dual-specific AH, whereas AHD appears
mono-specific to Dpy-30. Sequence comparisons of the representative AHs did not reveal
any consensus that will distinguish mono-specific or dual-specific AHs. The cross
reactivity may be more about the specific amino acids in individual AHs than the D/D
domain they bind to. Conversely, given the structural similarity between RI and Dpy-30,
it will be interesting to test if AHD, in RSP3, Ash2 or other molecules, can recognize the
RIIa domain from RI.
The dual-specific AHs in AKAPs bind PKA in both the RI or RII subunits.
However, the cross reactivity of AHR in vitro with Dpy-30 creates interesting dilemmas
in vivo —why does cross recognition not occur in the RS or in the cell body? If this
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occurred, the spokehead could potentially form at the middle of the stalk, rather than at
the expected distal end. Likewise, Dpy-30 is not expected to dock to AKAPs while PKA
is not known to be in the histone methyltransferase complex.
One may assume that there are determinants for the specificity. As most AHs tend
to be specific for RI or RII, perhaps the sequences in AHR and AHD are distinctive
enough to localize the respective effector mechanisms precisely. Or the difference in
affinity is sufficient to sort out the specificity that is observed in vivo. In general, the
affinity of the AHs for RI is lower than that for RII (Herberg et al., 2000). Thus RI is
often more evenly distributed throughout the cell body while RII is restricted to particular
loci (Kinderman et al., 2006). The third possibility is the most interesting-- the specificity
of certain AHs and the D/D are not as stringent as the connotations of these domains. In
fact the specificity could be facilitated by other molecular cues, like the flanking
sequences. It has been demonstrated that in dual-specific AKAPs, a sequence outside of
AHR contributes to RI recognition (Jarnaess et al., 2008). Similarly, the sequences
flanking the AHD in RSP3 and the Dpy-30 domain in RSP2 (Gopal et al., unpublished)
may be involved in interactions with each other and molecules in the vicinity. If this is
true, the AH and D/D domain may be more about docking and less about targeting. While
all the eyes are on the AH and D/D domains, the flanking sequences may be equally
informative.

5.6 Tools for the DAPs
The breadth and similarity of the AH and D/D domains presents ample opportunities yet
also poses conundrums for research. The AH-RIIa interaction has been exploited for
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discovering various AH-containing proteins that were recognized by RII. Two key tools
are RII and high-affinity AHs. RII is used as a ligand to identify molecules with AHs
(Lohmann et al., 1984). However, molecules could bind to RII ligand via sequences
irrelevant to the AH. Thus only the interactions that could be perturbed by the high
affinity AHs that originated from AKAPs are considered genuine (Carr et al., 1992).
These two key tools led to the discovery of many AKAPs. Similar tools suitable for the
Dpy-30 domain could potentially hasten the discoveries in the Dpy-30 field.
This study has demonstrated that Dpy-30 can serve as a ligand in pulldown or in
an overlay assay. The axonemal bands revealed by Dpy-30 overlay are similar, if not
identical, to that obtained by the RII overlay (Gaillard et al., 2001). This shows that AHD
in various molecules, not just in Ash2, can bind Dpy-30 in vitro and that Dpy-30 could be
used to discover other proteins that have an AHD, just like RII was used for the discovery
of AKAPs.
From a structural perspective, the ability to utilize Dpy-30 as a ligand is
interesting. RII exists as a homodimer, with the binding pocket exposed in solution.
However, purified Dpy-30 forms tetramers (Dong et al., 2005). The AH-binding pocket is
almost concealed in the tetramer (Wang et al., 2009). The results of the overlay assay and
the pulldown suggest that the pocket is still accessible to the AH. Also in the native gel,
Dpy-30 shifts in the opposite direction when it complexes with monomeric or dimeric
carrier-AHs. It is possible that dimeric AH may further pry open the Dpy-30 tetramers
into dimers.
Importantly, AHD in RSP3 cannot be recognized by RII (Gaillard et al., 2001) but
can be recognized by Dpy-30. Conversely, Dpy-30 recognizes AHD as well as AHR. The
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cross reactivity of Dpy-30 may be exploited in situations where using RII is not suitable.
In theory, Dpy-30 overlay can potentially be used as a general screen to reveal all
molecules with AHD or AHR, namely all DAPs. To sort out molecules that contain AHD
or AHR, two additional strategies can be employed. One is to develop a high affinity AH
for Dpy-30 domain. This AH, analogous to Ht-31, should be able to abolish the nonspecific interactions. It will be of interest to see if it is possible to develop AHs that
specifically disrupt the interaction of Dpy-30 with either AHD or AHR. For this purpose,
the existing reagents and methods could be developed into sensitive quantitative 96-well
assays either directly or through ELISA. Other high throughput systems, like peptide scan
on spot arrays can also aid in the identification of new high affinity AHs (Alto et al.,
2003, Burns-Hamuro et al., 2003). Once identified, the assay could be used to measure
the affinity of AH variants.
Aside from the overlay assay, the AHD with high affinity and high specificity for
Dpy-30 could be used in other perturbation assays, both in vitro as well as in vivo. Note
high affinity AHR, like membrane permeable variants of Ht-31, have been widely used to
study the significance of PKA anchoring in cell cultures or organ cultures. The effect is
not identical to PKA inhibitors (Vijayaraghavan et al., 1997). This could be due to the
inherent differences between the roles of PKA and AKAPs. It is also possible that some
of the AHR may disturb the interactions of Dpy-30. Likewise, it is foreseeable that a highaffinity AHD may modulate H3K4 methylation but in a slightly different way from Dpy30 knockdown or inhibitors of methyltransferases. Taken together, this dissertation will
hasten the expansion of the field of protein anchoring and docking. Modifications of the
new tools and assays will take the AH-D/D field to a robust future.
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